Detailed tables for the Canadian Student Tobacco, Alcohol and Drugs Survey 2021-2022

Table 1. Smoking status, by grade, Canada, 2021-22
Table 2. Smoking status, by grouped grades and gender, Canada, 2021-22
Table 3. Smoking status, by province and grouped grades, Canada, 2021-22
Table 4. Average number of whole cigarettes smoked per day in the past week among students who smoked daily, by grade, grouped grades and gender, Canada, 2021-22
Table 5. Ever tried e-cigarettes, by province, grouped grades and gender, Canada, 2021-22
Table 6. Past-30-day use of e-cigarettes, by province, grouped grades and gender, Canada, 2021-22
Table 7. Pattern of use of e-cigarettes in the past 30 days, by nicotine content, grouped grades and gender, Canada, 2021-22
Table 8. Perceived risk of harm from using cigarettes and e-cigarettes, Canada, 2021-22
Table 9. Ever tried a tobacco product, by grouped grades and gender, Canada, 2021-22
Table 10. Past-30-day use of a tobacco product, by grouped grades and gender, Canada, 2021-22
Table 11. Past-30-day use of cigarettes, e-cigarettes, any tobacco product, by province, gender and grouped grades, Canada, 2021-22
Table 12. Main reason for currently/continued vaping among students who vaped with nicotine in the past 30 days, by province, Canada, 2021-22
Table 13. Flavour vaped most often among students who vaped with nicotine in the past 30 days, by province, Canada, 2021-22
Table 14. Sources of cigarettes among students who smoked one or more cigarettes in the past 30 days, by province, Canada, 2021-22
Table 15. Sources of vaping devices among students who vaped with nicotine in the past 30 days, by province, Canada, 2021-22
Table 16. Sources of vaping e-liquids or pods among students who vaped with nicotine in the past 30 days, by province, Canada, 2021-22
Table 17. Past-30-day use of cigarettes, e-cigarettes, any tobacco product by self-reported mental health and gender, Canada, 2021-22
Table 18. Past-30-day use of cigarettes, e-cigarettes, any tobacco product by past-30-day experience with bullying and gender, Canada, 2021-22
Table 19. Past twelve-month use and mean age at first use of alcohol and cannabis, by grouped grades, Canada, 2021-2022
Table 20. Past twelve-month use and mean age at first use of alcohol and cannabis, by gender, Canada, 2021-2022
Table 21. Past twelve-month use of cannabis by past twelve-month use of alcohol, by gender and grouped grades, Canada, 2021-2022
Table 22. Past twelve-month use of illegal and other drugs, by grouped grades and gender, Canada, 2021-2022
Table 23. Past twelve-month use of medications to get high, by grouped grades and gender, Canada, 2021-2022
Table 24. Past twelve-month use of alcohol, cannabis and psychoactive pharmaceuticals, by province, Canada, 2021-2022
Table 25. Past twelve-month use of alcohol, cannabis and psychoactive pharmaceuticals, by grade, Canada, 2021-2022
Table 26. Past twelve-month methods of cannabis consumption among users, by grouped grades and gender, Canada, 2021-2022
Table 27. Past twelve-month use of alcohol and other drugs and medications on the same occasion, by grouped grades and gender, Canada, 2021-2022
Table 28. Past twelve-month use of opioids with other drugs and medications on the same occasion, by grouped grades and gender, Canada, 2021-2022
Table 29. Past-30-day frequency of being bullied, by grade group and gender, Canada, 2021-2022
Table 30. Past-30-day ways of being bullied, by grouped grades and gender, Canada, 2021-2022
Table 31. Past-30-day frequency of bullying others, by grade group and gender, Canada, 2021-2022
Table 32. Past-30-day ways of bullying others, by grouped grades and gender, Canada, 2021-2022
Table 33. Self-reported physical health, by grouped grades and gender, Canada, 2021-2022
Table 34. Self-reported mental health, by grouped grades and gender, Canada, 2021-2022
Table 35. Perceived risk of harm from using alcohol, cannabis, and prescription medication, Canada, 2021-2022
Table 36. Past twelve-month substance use by self-reported mental health and gender, Canada, 2021-2022
Table 37. Past twelve-month substance use by past-30-day experience with bullying and gender, Canada, 2021-22
Table 38. Sample size, by province and grade, Canada, 2021-2022

Table 1. Smoking status^{Footnote 1}, by grade, Canada^{Footnote 2}, 2021-22
	Pop'n estimate ('000)	Current daily smoking (%)	Current occasional smoking (%)	Former smoking or former experimental smoking (%)	Experimental smoking (%)	Tried smoking, but never smoked a whole cigarette (%)	Never tried smoking (%)
All grades (7-12)	2,144	1.2 [0.9-1.4]	0.8^{Footnote *} [0.5-1.1]	3.1 [2.6-3.7]	2.1 [1.6-2.6]	8.1 [7.4-8.8]	84.7 [82.8-86.7]
Grade 7^{Footnote 3}	352	0.2^{Footnote *} [0.1-0.3]	^{Footnote #}	0.8^{Footnote *} [0.5-1.0]	0.5^{Footnote ↑}^{Footnote *} [0.3-0.7]	3.6 [2.9-4.3]	94.8 [93.8-95.8]
Grade 8^{Footnote 4}	355	0.3^{Footnote *} [0.2-0.4]	0.3^{Footnote *} [0.1-0.4]	1.6 [1.2-1.9]	1.1 [0.8-1.4]	4.6 [4.0-5.2]	92.2 [91.2-93.2]
Grade 9^{Footnote 5}	381	1.2^{Footnote *} [0.6-1.8]	^{Footnote #}	2.4^{Footnote *} [1.5-3.4]	2.1^{Footnote *} [1.3-3.0]	7.5^{Footnote ↑} [6.2-8.9]	86.1 [83.1-89.2]
Grade 10^{Footnote 6}	380	1.5^{Footnote ↑}^{Footnote *} [0.8-2.3]	0.9^{Footnote *} [0.4-1.5]	3.4 [2.6-4.3]	1.7^{Footnote *} [1.1-2.3]	9.4 [7.8-10.9]	83.0 [80.5-85.5]
Grade 11^{Footnote 7}	378	1.5^{Footnote ↓}^{Footnote *} [0.9-2.1]	1.2^{Footnote *} [0.6-1.8]	5.2 [3.9-6.4]	3.3^{Footnote *} [1.6-5.0]	11.5^{Footnote ↓} [10.1-12.9]	77.4 [73.7-81.1]
Grade 12^{Footnote 8}	298	2.3^{Footnote *} [1.2-3.4]	2.2^{Footnote *} [1.0-3.4]	5.7 [4.1-7.2]	3.8^{Footnote *} [2.5-5.1]	12.4 [10.6-14.2]	73.7 [68.9-78.5]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Secondary I in Quebec. Return to footnote 3 referrer Footnote 4 Secondary II in Quebec. Return to footnote 4 referrer Footnote 5 Secondary III in Quebec. Return to footnote 5 referrer Footnote 6 Secondary IV in Quebec. Return to footnote 6 referrer Footnote 7 Secondary V in Quebec. Return to footnote 7 referrer Footnote 8 Excludes Quebec. Return to footnote 8 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote b High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to footnote # referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Estimates may not sum to 100 percent due to rounding. Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 2. Smoking status^{Footnote 1}, by grouped grades and gender, Canada^{Footnote 2}, 2021-22
	Current smoking^{Footnote 3} (%)	Current daily smoking (%)	Current occasional smoking (%)	Former smoking or former experimental smoking (%)	Experimental smoking (%)	Tried smoking, but never smoked a whole cigarette (%)	Never tried smoking (%)
All grades (7-12)	2.0 [1.5-2.5]	1.2 [0.9-1.4]	0.8^{Footnote *} [0.5-1.1]	3.1 [2.6-3.7]	2.1 [1.6-2.6]	8.1 [7.4-8.8]	84.7 [82.8-86.7]
Man/boy	1.9 [1.3-2.5]	1.1 [0.8-1.4]	0.8^{Footnote *} [0.5-1.1]	2.9 [2.2-3.6]	1.9^{Footnote *} [1.2-2.6]	7.5^{Footnote ↓} [6.5-8.5]	85.8 [83.4-88.2]
Woman/girl	1.6 [1.1-2.0]	0.8 [0.6-1.0]	0.8^{Footnote *} [0.5-1.1]	3.3 [2.8-3.8]	2.1 [1.5-2.6]	8.6 [7.7-9.5]	84.4 [82.5-86.3]
Transgender, gender diverse, and/or questioning	3.6^{Footnote *} [1.6-5.6]	2.0^{Footnote *} [1.3-2.7]	^{Footnote #}	3.8 [2.8-4.8]	4.7^{Footnote *} [2.9-6.4]	10.9 [8.6-13.3]	77.0 [73.6-80.4]
Grades 7-9^{Footnote 4}	0.9 [0.6-1.2]	0.6^{Footnote *} [0.4-0.8]	0.3^{Footnote *} [0.1-0.4]	1.6 [1.2-2.0]	1.3 [0.9-1.6]	5.3 [4.6-6.0]	90.9 [89.5-92.3]
Man/boy	0.9^{Footnote *} [0.5-1.4]	0.7^{Footnote *} [0.3-1.0]	^{Footnote #}	1.2 [0.9-1.6]	1.0^{Footnote *} [0.6-1.4]	4.8 [4.0-5.6]	92.1 [90.5-93.6]
Woman/girl	0.5^{Footnote ↑}^{Footnote *} [0.3-0.7]	0.2^{Footnote *} [0.1-0.3]	0.3^{Footnote *} [0.2-0.5]	1.9^{Footnote *} [1.3-2.5]	1.4 [1.0-1.8]	5.5^{Footnote ↑} [4.7-6.3]	90.7 [89.3-92.1]
Transgender, gender diverse, and/or questioning	1.8^{Footnote *} [0.7-3.0]	^{Footnote #}	^{Footnote #}	3.1^{Footnote *} [2.0-4.2]	3.9^{Footnote *} [2.2-5.6]	8.8^{Footnote *} [5.5-12.1]	82.3 [79.2-85.5]
Grades 10-12^{Footnote 5}	3.1 [2.2-4.0]	1.7 [1.3-2.1]	1.4^{Footnote *} [0.8-1.9]	4.7 [3.6-5.7]	2.9 [2.0-3.8]	11.0 [9.9-12.0]	78.4 [75.3-81.5]
Man/boy	3.0 [2.1-3.9]	1.6 [1.1-2.1]	1.4^{Footnote *} [0.8-1.9]	4.7 [3.3-6.1]	2.9^{Footnote *} [1.5-4.2]	10.3 [8.9-11.8]	79.1 [75.5-82.7]
Woman/girl	2.7^{Footnote *} [1.8-3.6]	1.4 [1.0-1.8]	1.3^{Footnote *} [0.7-1.9]	4.7 [3.8-5.7]	2.8^{Footnote *} [1.8-3.8]	11.8 [10.2-13.4]	77.9 [74.3-81.5]
Transgender, gender diverse, and/or questioning	^{Footnote #}	2.6^{Footnote *} [1.4-3.8]	^{Footnote #}	4.6^{Footnote *} [2.9-6.2]	5.6^{Footnote *} [3.1-8.0]	13.5^{Footnote ↑} [9.4-17.6]	70.6 [65.2-76.1]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Current smoking includes daily smoking and occasional (non-daily) smoking. Return to footnote 3 referrer Footnote 4 Secondary I-III in Quebec. Return to footnote 4 referrer Footnote 5 Secondary IV-V in Quebec. Return to footnote 5 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote b High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to footnote # referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Estimates may not sum to 100 percent due to rounding. Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 3. Smoking status^{Footnote 1}, by province and grouped grades, Canada^{Footnote 2}, 2021-22
	Pop'n estimate ('000)	Current smoking^{Footnote 3} (%)	Former smoking or former experimental smoking (%)	Experimental smoking (%)	Tried smoking, but never smoked a whole cigarette (%)	Never tried smoking (%)
Canada^{Footnote 2}	2,144	2.0 [1.5-2.5]	3.1 [2.6-3.7]	2.1 [1.6-2.6]	8.1 [7.4-8.8]	84.7 [82.8-86.7]
Grades 7-9^{Footnote 4}	1,088	0.9 [0.6-1.2]	1.6 [1.2-2.0]	1.3 [0.9-1.6]	5.3 [4.6-6.0]	90.9 [89.5-92.3]
Grades 10-12^{Footnote 5}	1,056	3.1 [2.2-4.0]	4.7 [3.6-5.7]	2.9 [2.0-3.8]	11.0 [9.9-12.0]	78.4 [75.3-81.5]
NL	26	2.5^{Footnote ↓} [1.8-3.2]	5.7 [5.1-6.4]	2.7 [2.2-3.2]	10.2 [9.2-11.3]	78.8 [77.0-80.6]
Grades 7-9	14	1.2^{Footnote *} [0.7-1.6]	2.5^{Footnote ↓} [2.0-3.0]	1.7 [1.2-2.2]	6.7 [5.3-8.0]	88.0 [86.2-89.8]
Grades 10-12	12	4.0^{Footnote *} [2.6-5.4]	9.5^{Footnote ↑} [8.3-10.7]	3.9 [3.0-4.8]	14.4 [13.0-15.9]	68.1 [64.9-71.3]
PE	10	2.0 [1.6-2.4]	3.5^{Footnote ↓} [2.9-4.0]	3.1 [2.3-3.9]	9.0 [8.1-9.9]	82.4 [81.0-83.9]
Grades 7-9	5	^{Footnote #}	^{Footnote #}	1.6 [1.1-2.1]	5.1 [4.3-6.0]	91.4 [90.1-92.6]
Grades 10-12	5	3.1 [2.3-3.9]	5.6 [4.6-6.6]	4.5^{Footnote ↑} [3.1-5.9]	12.6 [11.2-14.1]	74.1 [71.6-76.6]
NS	54	2.7^{Footnote *} [1.7-3.7]	5.3 [4.0-6.5]	2.8 [2.2-3.4]	9.5^{Footnote ↓} [8.4-10.5]	79.7 [76.4-83.0]
Grades 7-9	26	1.3^{Footnote *} [0.8-1.8]	2.0^{Footnote *} [1.3-2.7]	1.9 [1.3-2.5]	5.5^{Footnote ↓} [4.3-6.6]	89.3 [87.2-91.4]
Grades 10-12	28	4.0^{Footnote *} [2.2-5.7]	8.3 [5.9-10.7]	3.7 [2.9-4.6]	13.2 [11.4-15.0]	70.8 [65.0-76.6]
QC	392	1.3 [0.9-1.7]	3.1 [2.1-4.1]	1.3^{Footnote *} [0.8-1.9]	9.6 [8.1-11.1]	84.6 [81.7-87.6]
Secondary I-III	236	0.9^{Footnote *} [0.6-1.1]	1.8^{Footnote *} [1.1-2.6]	1.0^{Footnote *} [0.5-1.5]	7.6 [5.7-9.5]	88.7 [85.6-91.8]
Secondary IV-V	156	2.0^{Footnote *} [1.3-2.7]	5.1 [3.5-6.6]	1.8^{Footnote *} [1.2-2.5]	12.6 [11.4-13.8]	78.5^{Footnote ↑} [75.6-81.5]
ON	926	2.1^{Footnote *} [1.1-3.2]	2.7^{Footnote *} [1.6-3.8]	2.2^{Footnote *} [1.1-3.3]	6.8 [5.6-8.0]	86.1 [82.2-90.1]
Grades 7-9	443	^{Footnote #}	1.4^{Footnote *} [0.6-2.1]	1.4^{Footnote *} [0.6-2.1]	3.9 [2.7-5.2]	92.4 [89.7-95.1]
Grades 10-12	484	3.2^{Footnote *} [1.5-4.9]	4.0^{Footnote *} [2.0-5.9]	3.0^{Footnote *} [1.1-4.9]	9.4 [7.8-11.1]	80.4 [74.5-86.3]
MB	85	^{Footnote #}	^{Footnote #}	^{Footnote #}	10.6^{Footnote *} [5.0-16.3]	81.7 [71.9-91.5]
Grades 7-9	42	^{Footnote #}	^{Footnote #}	^{Footnote #}	5.8^{Footnote *} [3.4-8.2]	90.8 [86.0-95.7]
Grades 10-12	43	^{Footnote #}	^{Footnote #}	^{Footnote #}	15.3^{Footnote *} [5.6-25.0]	72.9 [56.4-89.4]
SK	70	^{Footnote #}	5.0 [4.0-5.9]	3.6^{Footnote *} [2.3-4.8]	11.5^{Footnote ↑} [9.7-13.3]	75.6 [70.1-81.1]
Grades 7-9	35	1.2^{Footnote *} [0.5-1.9]	2.7 [2.2-3.1]	2.0^{Footnote *} [1.1-2.9]	7.3 [5.6-9.0]	86.9 [83.8-90.0]
Grades 10-12	35	^{Footnote #}	7.2 [5.6-8.9]	5.1^{Footnote *} [3.1-7.2]	15.7 [13.0-18.4]	64.3 [55.7-72.9]
AB	285	1.7^{Footnote *} [1.1-2.3]	2.7 [2.0-3.4]	1.7 [1.2-2.2]	7.4 [6.0-8.8]	86.5^{Footnote ↓} [83.9-89.1]
Grades 7-9	141	0.9^{Footnote *} [0.5-1.4]	1.4^{Footnote *} [0.9-1.9]	1.2^{Footnote *} [0.7-1.7]	5.5^{Footnote ↑} [4.3-6.8]	90.9 [88.8-93.0]
Grades 10-12	144	2.4^{Footnote *} [1.3-3.5]	3.9^{Footnote *} [2.6-5.3]	2.2^{Footnote *} [1.4-3.1]	9.3 [6.8-11.8]	82.2 [77.5-86.8]
BC	296	1.8^{Footnote *} [0.8-2.7]	3.8^{Footnote *} [2.2-5.3]	2.3^{Footnote *} [1.4-3.1]	8.8 [6.5-11.1]	83.4 [78.1-88.7]
Grades 7-9	147	^{Footnote #}	1.7^{Footnote *} [1.1-2.3]	^{Footnote #}	4.7 [3.3-6.1]	91.6 [88.6-94.6]
Grades 10-12	149	2.8^{Footnote *} [1.1-4.5]	5.8^{Footnote *} [2.8-8.8]	3.2^{Footnote *} [1.8-4.7]	12.8 [9.0-16.6]	75.4 [66.5-84.3]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Current smoking includes daily smoking and occasional (non-daily) smoking. Return to footnote 3 referrer Footnote 4 Secondary I-III in Quebec. Return to footnote 4 referrer Footnote 5 Secondary IV-V in Quebec. Return to footnote 5 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote b High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to footnote # referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Estimates may not sum to 100 percent due to rounding. Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 4. Average number of whole cigarettes smoked per day in the past week among students who smoked daily^{Footnote 1}, by grade, grouped grades and gender, Canada^{Footnote 2}, 2021-22
	Total	Man/boy	Woman/girl	Transgender, gender diverse, and/or questioning
All grades (7-12)	6.0 [5.1-6.9]	6.3 [5.3-7.2]	4.8 [3.5-6.1]	4.9^{Footnote *} [2.5-7.2]
Grades 7-9^{Footnote 3}	6.6 [5.5-7.7]	6.7 [5.7-7.7]	5.8^{Footnote *} [3.9-7.7]	^{Footnote #}
Grades 10-12^{Footnote 4}	5.8 [4.5-7.1]	6.1 [4.6-7.6]	4.6 [3.2-6.1]	^{Footnote #}
Grade 7^{Footnote 5}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
Grade 8^{Footnote 6}	8.1 [5.9-10.3]	^{Footnote #}	^{Footnote #}	^{Footnote #}
Grade 9^{Footnote 7}	6.0 [4.8-7.2]	6.2 [5.1-7.4]	^{Footnote #}	^{Footnote #}
Grade 10^{Footnote 8}	4.7^{Footnote *} [2.2-7.3]	^{Footnote #}	^{Footnote #}	^{Footnote #}
Grade 11^{Footnote 9}	6.0 [4.6-7.5]	6.1 [4.6-7.7]	4.2^{Footnote *} [2.7-5.8]	^{Footnote #}
Grade 12^{Footnote 10}	6.5^{Footnote ↑}^{Footnote *} [4.2-8.9]	6.6^{Footnote *} [4.0-9.1]	5.7^{Footnote *} [3.2-8.2]	^{Footnote #}
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Secondary I-III in Quebec. Return to footnote 3 referrer Footnote 4 Secondary IV-V in Quebec. Return to footnote 4 referrer Footnote 5 Secondary I in Quebec. Return to footnote 5 referrer Footnote 6 Secondary II in Quebec. Return to footnote 6 referrer Footnote 7 Secondary III in Quebec. Return to footnote 7 referrer Footnote 8 Secondary IV in Quebec. Return to footnote 8 referrer Footnote 9 Secondary V in Quebec. Return to footnote 9 referrer Footnote 10 Excludes Quebec. Return to footnote 10 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote b High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to footnote # referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 5. Ever tried e-cigarettes^{Footnote 1}, by province, grouped grades and gender, Canada^{Footnote 2}, 2021-22

Table 5. Ever tried e-cigarettes^{Footnote 1}, by province, grouped grades and gender, Canada^{Footnote 2}, 2021-22
	Overall^{Footnote 3}				With nicotine				Without nicotine				Did not know what it contained
	Total (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)	Total (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)	Total (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)	Total (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)
Canada^{Footnote 2}	29.4 [26.8-32.0]	26.1 [23.0-29.2]	32.2 [29.3-35.0]	31.8 [28.7-34.9]	26.3 [23.8-28.9]	23.2 [20.2-26.2]	29.1 [26.3-32.0]	26.6 [22.5-30.7]	16.4 [14.8-18.0]	15.3 [13.4-17.2]	17.1 [15.2-18.9]	17.6 [15.4-19.7]	12.7 [11.3-14.2]	10.5^{Footnote ↓} [8.8-12.1]	14.5^{Footnote ↓} [12.9-16.1]	15.6 [13.4-17.8]
Grades 7-9^{Footnote 4}	18.3 [16.1-20.5]	15.6 [13.1-18.0]	20.3 [17.8-22.7]	26.3 [22.2-30.3]	15.5^{Footnote ↓} [13.4-17.6]	13.1 [10.8-15.3]	17.6 [15.3-19.9]	19.9 [15.9-23.8]	9.4 [7.9-10.9]	8.2 [6.7-9.7]	10.1 [8.4-11.8]	14.2 [10.5-17.9]	7.8 [6.6-9.0]	6.0 [4.7-7.2]	9.0 [7.8-10.2]	13.6 [10.2-17.0]
Grades 10-12^{Footnote 5}	40.8 [37.1-44.5]	37.2 [32.7-41.8]	44.4 [39.5-49.3]	38.2 [33.6-42.8]	37.4 [33.6-41.2]	33.9 [29.6-38.3]	41.0 [36.1-45.8]	34.5^{Footnote ↑} [29.3-39.8]	23.5^{Footnote ↑} [21.3-25.8]	22.9 [20.0-25.7]	24.2 [21.3-27.1]	21.5^{Footnote ↓} [18.2-24.7]	17.8 [15.7-19.9]	15.2 [12.8-17.7]	20.2 [17.2-23.2]	17.9 [14.4-21.4]
NL	40.5^{Footnote ↑} [38.7-42.4]	37.6 [35.8-39.3]	44.0 [41.7-46.2]	37.8 [31.5-44.1]	37.6 [35.7-39.5]	34.4 [32.6-36.2]	41.6 [39.3-43.8]	32.1 [26.4-37.9]	22.2 [20.9-23.4]	21.6 [20.1-23.1]	22.8 [21.0-24.6]	19.7 [15.4-24.0]	19.2 [17.9-20.4]	17.0 [15.8-18.2]	20.9 [18.9-22.8]	23.0 [18.3-27.6]
Grades 7-9	25.4 [22.7-28.1]	21.4 [18.7-24.1]	29.4 [26.2-32.5]	27.2 [18.8-35.7]	22.9 [20.4-25.4]	18.5^{Footnote ↑} [16.0-21.1]	27.6 [24.6-30.5]	23.1^{Footnote *} [15.4-30.7]	11.1 [9.7-12.5]	9.8 [8.2-11.5]	11.8 [9.9-13.8]	^{Footnote #}	10.6 [9.0-12.2]	9.1 [7.6-10.7]	11.5^{Footnote ↑} [9.8-13.2]	^{Footnote #}
Grades 10-12	57.6 [55.1-60.1]	56.1 [53.6-58.5]	60.1 [56.6-63.5]	50.4 [42.0-58.7]	54.2 [51.5-57.0]	52.7 [50.2-55.3]	57.0 [53.5-60.5]	43.2 [34.8-51.5]	34.9 [32.9-36.9]	35.3 [32.7-38.0]	35.0 [32.2-37.9]	27.2 [19.5-34.9]	29.1 [26.8-31.3]	26.2 [24.1-28.4]	31.4 [27.5-35.2]	31.7 [24.1-39.3]
PE	34.0 [32.1-35.8]	31.5^{Footnote ↑} [29.2-33.8]	36.6 [34.0-39.1]	31.2 [27.2-35.2]	30.8 [28.8-32.9]	28.9 [26.4-31.4]	33.1 [30.5-35.7]	26.9 [22.8-30.9]	17.9 [16.7-19.1]	16.7 [15.0-18.3]	19.1 [17.0-21.1]	18.0 [15.1-20.9]	14.8 [13.7-15.9]	13.0 [11.8-14.2]	16.4 [14.8-17.9]	16.6 [13.0-20.1]
Grades 7-9	17.6 [15.7-19.5]	15.7 [13.3-18.2]	19.2 [16.4-22.0]	^{Footnote #}	14.8 [12.9-16.6]	13.0 [10.3-15.7]	16.2 [13.5-18.9]	^{Footnote #}	8.3 [7.2-9.4]	7.5^{Footnote ↓} [6.0-8.9]	8.6 [7.2-10.1]	^{Footnote #}	7.5^{Footnote ↓} [6.4-8.5]	6.0 [4.4-7.5]	8.4 [7.0-9.9]	^{Footnote #}
Grades 10-12	48.9 [45.7-52.0]	45.5^{Footnote ↑} [41.6-49.4]	52.4 [48.2-56.5]	45.1 [39.5-50.7]	45.5^{Footnote ↓} [41.9-49.1]	42.8 [38.6-47.1]	48.5^{Footnote ↓} [44.1-52.8]	^{Footnote #}	26.7 [24.5-28.8]	24.9 [21.9-27.8]	28.6 [24.8-32.3]	^{Footnote #}	21.6 [19.7-23.6]	19.3 [17.4-21.2]	23.7 [20.9-26.4]	^{Footnote #}
NS	38.3 [34.0-42.5]	34.8 [29.9-39.7]	42.9 [39.3-46.5]	31.7 [22.2-41.2]	35.7 [32.0-39.3]	32.7 [28.1-37.3]	40.1 [37.4-42.9]	26.5^{Footnote ↑}^{Footnote *} [17.3-35.8]	20.3 [17.6-23.1]	18.6 [15.3-22.0]	22.1 [19.8-24.4]	20.6^{Footnote *} [13.3-27.8]	17.5^{Footnote ↑} [15.4-19.7]	14.7 [12.3-17.1]	20.2 [18.2-22.3]	17.2^{Footnote *} [11.0-23.4]
Grades 7-9	20.3 [17.2-23.3]	17.0 [14.3-19.8]	23.5^{Footnote ↓} [19.2-27.8]	24.5^{Footnote ↓} [18.7-30.2]	17.8 [15.0-20.6]	14.8 [12.0-17.6]	21.4 [17.6-25.2]	17.9 [12.7-23.0]	10.0 [8.1-11.8]	9.1 [7.5-10.7]	10.6 [7.9-13.3]	13.3^{Footnote *} [8.2-18.3]	9.3 [7.4-11.1]	7.0 [5.2-8.9]	11.3 [8.9-13.8]	12.8^{Footnote *} [7.4-18.2]
Grades 10-12	54.5^{Footnote ↑} [47.6-61.5]	51.0 [42.7-59.3]	60.0 [55.1-65.0]	38.8^{Footnote *} [18.9-58.8]	51.8 [46.0-57.6]	48.9 [41.2-56.6]	56.7 [53.4-60.0]	34.8^{Footnote *} [16.6-53.0]	29.8 [25.6-34.1]	27.5^{Footnote ↓} [21.8-33.2]	32.4 [29.2-35.6]	27.6^{Footnote *} [12.7-42.5]	25.0 [21.7-28.4]	21.8 [18.0-25.7]	28.0 [25.4-30.7]	^{Footnote #}
QC	33.5^{Footnote ↑} [26.9-40.2]	29.2 [23.2-35.3]	37.2 [29.6-44.8]	37.6 [29.8-45.4]	29.6 [23.2-36.1]	25.1 [19.2-31.0]	33.6 [26.2-41.0]	33.6 [25.9-41.4]	20.8 [16.0-25.7]	18.8 [14.3-23.3]	22.2 [16.8-27.7]	23.0 [18.0-28.0]	14.9 [12.1-17.7]	12.2 [9.5-14.9]	17.0 [14.0-20.0]	18.0 [13.0-23.1]
Secondary I-III	25.6 [17.9-33.3]	22.1 [15.2-29.0]	28.2 [19.3-37.2]	29.7 [21.3-38.1]	22.1^{Footnote *} [14.8-29.4]	18.3^{Footnote *} [11.8-24.9]	25.1^{Footnote *} [16.7-33.6]	26.0 [18.1-33.9]	15.4^{Footnote *} [10.1-20.8]	13.8^{Footnote *} [8.9-18.7]	16.4^{Footnote *} [10.3-22.4]	17.3^{Footnote *} [11.6-23.0]	11.1 [7.6-14.6]	8.8^{Footnote *} [5.6-12.1]	12.5^{Footnote ↑} [8.6-16.5]	15.0^{Footnote *} [9.9-20.1]
Secondary IV-V	45.5^{Footnote ↑} [39.9-51.1]	39.9 [34.4-45.4]	50.5^{Footnote ↓} [44.0-57.0]	51.2 [41.3-61.2]	40.9 [34.9-46.9]	35.2 [29.2-41.2]	46.3 [39.5-53.0]	47.0 [36.7-57.4]	29.0 [24.7-33.3]	26.3 [21.8-30.7]	31.0 [26.1-36.0]	33.1 [25.9-40.3]	20.7 [17.6-23.9]	17.2 [13.7-20.7]	23.7 [20.3-27.1]	^{Footnote #}
ON	27.0 [22.5-31.4]	23.6 [17.4-29.7]	28.8 [23.6-34.1]	29.6 [23.9-35.4]	24.0 [19.5-28.5]	21.0 [15.0-27.0]	25.7 [20.4-31.0]	24.2^{Footnote *} [15.2-33.2]	14.5^{Footnote ↑} [12.2-16.9]	13.6 [10.2-17.0]	14.5^{Footnote ↑} [11.4-17.6]	16.8 [13.2-20.4]	11.8 [9.1-14.6]	9.8^{Footnote *} [6.4-13.3]	13.1 [9.6-16.6]	14.9 [10.9-19.0]
Grades 7-9	15.0 [11.9-18.1]	13.5^{Footnote ↓}^{Footnote *} [9.0-18.0]	15.5^{Footnote ↓} [12.7-18.3]	22.5^{Footnote ↑}^{Footnote *} [15.1-30.0]	12.5^{Footnote ↑} [9.6-15.4]	11.8^{Footnote *} [7.7-16.0]	12.7 [10.0-15.5]	^{Footnote #}	7.2 [5.2-9.1]	6.4^{Footnote *} [4.1-8.7]	7.3 [5.3-9.3]	^{Footnote #}	6.4 [4.4-8.4]	5.2^{Footnote *} [2.7-7.6]	6.8 [5.0-8.5]	^{Footnote #}
Grades 10-12	37.9 [31.5-44.3]	33.4 [24.8-41.9]	41.5^{Footnote ↑} [31.8-51.3]	36.5^{Footnote ↓} [28.5-44.4]	34.6 [27.9-41.3]	30.0 [21.6-38.3]	38.0 [28.4-47.7]	33.7 [23.6-43.7]	21.3 [17.9-24.7]	20.7 [15.8-25.6]	21.4 [15.9-26.9]	^{Footnote #}	16.8 [12.9-20.7]	14.4 [9.7-19.1]	19.2^{Footnote *} [12.8-25.5]	^{Footnote #}
MB	28.7 [21.7-35.6]	23.8 [17.0-30.6]	32.6 [22.5-42.8]	29.5^{Footnote ↓}^{Footnote *} [18.5-40.5]	25.6 [18.7-32.5]	21.0^{Footnote *} [14.0-27.9]	29.7 [20.3-39.0]	^{Footnote #}	16.8 [11.9-21.7]	13.9^{Footnote *} [8.5-19.3]	18.6^{Footnote *} [12.0-25.2]	^{Footnote #}	11.4^{Footnote *} [6.3-16.4]	^{Footnote #}	12.7 [9.0-16.4]	^{Footnote #}
Grades 7-9	15.2 [11.5-18.9]	11.7 [8.3-15.1]	16.8 [12.9-20.8]	^{Footnote #}	12.6 [9.7-15.6]	8.9 [6.2-11.7]	15.1 [11.5-18.7]	^{Footnote #}	7.6 [5.6-9.7]	6.3 [4.4-8.2]	7.9^{Footnote *} [5.2-10.7]	^{Footnote #}	6.4^{Footnote *} [3.7-9.0]	4.5^{Footnote ↓}^{Footnote *} [2.7-6.3]	7.1^{Footnote *} [4.1-10.1]	^{Footnote #}
Grades 10-12	41.3 [29.4-53.3]	35.8^{Footnote *} [23.2-48.3]	46.6^{Footnote *} [28.8-64.3]	^{Footnote #}	37.9 [25.5-50.2]	32.8^{Footnote *} [19.5-46.1]	42.8^{Footnote *} [25.7-59.9]	^{Footnote #}	25.5^{Footnote ↓}^{Footnote *} [16.2-34.7]	21.5^{Footnote ↓}^{Footnote *} [10.9-32.1]	28.2^{Footnote *} [15.7-40.6]	^{Footnote #}	16.1^{Footnote *} [6.3-26.0]	^{Footnote #}	^{Footnote #}	^{Footnote #}
SK	37.9 [34.8-41.0]	35.0 [31.6-38.5]	40.7 [37.1-44.3]	39.8 [30.0-49.6]	34.9 [31.9-38.0]	32.3 [28.8-35.8]	37.8 [34.3-41.3]	33.1 [24.2-42.0]	20.2 [17.9-22.5]	19.5^{Footnote ↑} [16.9-22.2]	20.4 [17.7-23.2]	22.1 [15.4-28.7]	15.3 [14.1-16.4]	12.6 [10.6-14.5]	17.5^{Footnote ↑} [15.6-19.5]	18.5^{Footnote ↓} [12.7-24.2]
Grades 7-9	22.7 [20.1-25.3]	18.9 [16.2-21.7]	25.8 [22.2-29.4]	31.3 [21.2-41.4]	19.5^{Footnote ↓} [17.0-21.9]	16.4 [13.8-19.0]	22.3 [18.9-25.8]	23.7^{Footnote *} [15.1-32.4]	11.5^{Footnote ↑} [9.8-13.2]	9.9 [7.7-12.0]	12.8 [10.3-15.2]	^{Footnote #}	9.9 [8.5-11.3]	7.2 [5.4-8.9]	12.1 [10.0-14.1]	^{Footnote #}
Grades 10-12	52.8 [48.1-57.5]	50.9 [45.4-56.5]	55.0 [50.0-60.0]	50.3 [40.0-60.7]	50.1 [45.3-54.8]	48.1 [42.1-54.0]	52.6 [47.8-57.5]	44.9 [34.8-55.0]	28.8 [25.3-32.3]	29.3 [25.0-33.6]	27.9 [23.9-31.9]	^{Footnote #}	20.6 [18.5-22.6]	18.0 [14.9-21.1]	22.9 [19.7-26.1]	^{Footnote #}
AB	26.7 [22.6-30.7]	23.9 [19.9-27.9]	28.5^{Footnote ↑} [23.7-33.4]	36.7 [29.6-43.7]	23.5^{Footnote ↑} [19.8-27.2]	20.5^{Footnote ↑} [17.1-24.0]	26.0 [21.3-30.6]	30.1 [22.9-37.2]	14.2 [12.0-16.4]	13.6 [11.2-16.1]	14.4 [12.1-16.6]	17.9^{Footnote *} [11.7-24.0]	10.9 [9.3-12.5]	9.2 [7.5-10.9]	12.0 [9.9-14.1]	16.1 [11.8-20.4]
Grades 7-9	17.6 [15.0-20.1]	13.8 [11.4-16.2]	20.0 [17.0-23.0]	32.9 [22.5-43.3]	14.3 [12.3-16.3]	10.3 [8.5-12.1]	17.4 [14.6-20.3]	25.9^{Footnote *} [15.4-36.4]	8.6 [6.9-10.4]	7.2 [5.2-9.3]	9.4 [7.7-11.1]	16.0^{Footnote *} [9.0-23.0]	6.9 [6.0-7.8]	4.9 [4.0-5.8]	8.3 [6.6-10.0]	14.1^{Footnote *} [8.7-19.4]
Grades 10-12	35.5^{Footnote ↓} [27.7-43.2]	33.7 [26.0-41.5]	36.6 [27.4-45.7]	41.1 [31.4-50.7]	32.4 [25.3-39.5]	30.5^{Footnote ↑} [23.8-37.2]	34.1 [25.1-43.0]	34.9 [25.3-44.5]	19.6 [15.5-23.7]	20.0 [15.4-24.6]	19.0 [14.7-23.3]	20.0^{Footnote *} [9.9-30.1]	14.7 [11.6-17.9]	13.3 [10.0-16.7]	15.4 [11.5-19.4]	18.5^{Footnote ↑}^{Footnote *} [11.4-25.6]
BC	29.8 [22.2-37.4]	27.1 [19.0-35.2]	33.0 [25.2-40.8]	24.6^{Footnote *} [15.4-33.8]	27.1 [19.9-34.4]	25.0 [17.4-32.7]	30.1 [22.7-37.4]	20.9^{Footnote *} [13.5-28.4]	16.0 [11.2-20.7]	15.2^{Footnote *} [10.1-20.4]	16.9 [11.9-21.9]	11.9^{Footnote *} [7.8-15.9]	12.7 [9.5-16.0]	9.9^{Footnote *} [6.3-13.5]	15.5^{Footnote ↑} [12.3-18.7]	13.1^{Footnote *} [6.7-19.4]
Grades 7-9	15.8 [11.9-19.8]	12.1 [8.6-15.6]	18.8 [14.3-23.3]	22.6^{Footnote *} [14.3-30.8]	13.7 [10.0-17.5]	10.4 [7.1-13.8]	16.8 [12.4-21.2]	17.6^{Footnote *} [11.2-24.1]	6.9 [5.1-8.6]	5.2 [3.8-6.6]	7.8 [5.5-10.2]	^{Footnote #}	6.8 [4.6-9.0]	4.3 [3.0-5.6]	9.1 [6.2-12.0]	^{Footnote #}
Grades 10-12	43.2 [30.3-56.1]	41.5^{Footnote ↑} [28.1-54.9]	46.1 [32.2-60.0]	^{Footnote #}	40.1 [28.0-52.1]	39.1 [26.4-51.7]	42.5^{Footnote ↓} [29.5-55.5]	^{Footnote #}	24.8^{Footnote *} [15.9-33.6]	25.0^{Footnote *} [15.5-34.5]	25.4^{Footnote *} [16.2-34.6]	^{Footnote #}	18.5^{Footnote ↓} [12.6-24.3]	15.4^{Footnote *} [8.9-21.8]	21.6 [15.4-27.7]	^{Footnote #}
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Use of e-cigarettes with nicotine, without nicotine, and/or with an unknown content. Return to footnote 3 referrer Footnote 4 Secondary I-III in Quebec. Return to footnote 4 referrer Footnote 5 Secondary IV-V in Quebec. Return to footnote 5 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote b High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to footnote # referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 6. Past-30-day use of e-cigarettes^{Footnote 1}, by province, grouped grades and gender, Canada^{Footnote 2}, 2021-22

Table 6. Past-30-day use of e-cigarettes^{Footnote 1}, by province, grouped grades and gender, Canada^{Footnote 2}, 2021-22
	Overall^{Footnote 3}				With nicotine				Without nicotine				Did not know what it contained
	Total (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)	Total (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)	Total (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)	Total (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)
Canada^{Footnote 2}	16.8 [14.5-19.1]	14.6 [11.9-17.4]	18.6 [16.1-21.2]	17.8 [15.3-20.2]	15.7 [13.4-18.0]	13.7 [10.9-16.6]	17.6 [15.2-19.9]	15.1 [12.0-18.2]	4.3 [3.7-5.0]	4.1 [3.2-4.9]	4.0 [3.5-4.5]	6.2^{Footnote *} [4.1-8.3]	5.1 [4.2-5.9]	4.3 [3.1-5.5]	5.4 [4.6-6.2]	5.9 [4.7-7.0]
Grades 7-9^{Footnote 4}	10.1 [8.4-11.7]	8.1 [6.4-9.9]	11.5^{Footnote ↓} [9.6-13.4]	14.6 [11.4-17.9]	9.1 [7.5-10.7]	7.5^{Footnote ↓} [5.7-9.2]	10.6 [8.7-12.4]	11.2 [8.6-13.8]	3.3 [2.7-4.0]	2.8 [2.1-3.5]	3.4 [2.7-4.0]	5.8^{Footnote *} [2.8-8.8]	3.4 [2.7-4.2]	2.6 [1.8-3.3]	4.0 [3.1-4.8]	5.1 [3.6-6.6]
Grades 10-12^{Footnote 5}	23.6 [20.2-27.1]	21.5^{Footnote ↓} [17.3-25.6]	26.0 [21.4-30.6]	21.4 [17.4-25.4]	22.4 [18.9-26.0]	20.4 [16.0-24.8]	24.8 [20.5-29.0]	19.8 [15.3-24.3]	5.4 [4.5-6.3]	5.4 [4.1-6.8]	4.7 [4.0-5.4]	6.7^{Footnote *} [3.8-9.6]	6.7 [5.5-8.0]	6.2 [4.3-8.1]	6.8 [5.6-8.1]	6.8 [5.0-8.6]
NL	26.6 [25.0-28.3]	24.9 [23.1-26.7]	28.9 [27.0-30.8]	21.0 [16.5-25.4]	25.6 [23.9-27.4]	23.8 [21.9-25.7]	27.9 [26.0-29.8]	20.6 [16.2-25.0]	5.7 [5.1-6.3]	6.1 [5.3-6.9]	5.1 [4.3-5.8]	^{Footnote #}	9.4 [8.3-10.5]	8.8 [7.5-10.1]	10.0 [8.9-11.0]	^{Footnote #}
Grades 7-9	15.3 [13.2-17.3]	12.3 [10.4-14.2]	18.4 [15.8-21.1]	^{Footnote #}	14.4 [12.4-16.4]	11.5^{Footnote ↓} [9.6-13.4]	17.6 [15.0-20.2]	^{Footnote #}	3.5^{Footnote ↑} [2.8-4.2]	3.5^{Footnote ↑} [2.5-4.6]	3.1 [2.4-3.9]	^{Footnote #}	5.0 [3.9-6.1]	4.0 [2.8-5.2]	5.8 [4.5-7.1]	^{Footnote #}
Grades 10-12	39.5^{Footnote ↓} [36.6-42.4]	39.3 [35.8-42.7]	40.5^{Footnote ↓} [37.6-43.3]	30.1 [24.0-36.2]	38.3 [35.3-41.3]	38.0 [34.5-41.5]	39.2 [36.3-42.2]	29.9 [23.7-36.1]	8.2 [7.3-9.2]	9.0 [7.7-10.4]	7.2 [5.9-8.5]	^{Footnote #}	14.5^{Footnote ↑} [12.6-16.5]	14.4 [11.9-17.0]	14.6 [12.8-16.4]	^{Footnote #}
PE	20.0 [18.1-22.0]	20.2 [17.8-22.6]	20.0 [17.7-22.2]	^{Footnote #}	19.2 [17.2-21.2]	19.1 [16.7-21.5]	19.4 [17.2-21.6]	^{Footnote #}	4.2 [3.8-4.7]	4.4 [3.7-5.0]	3.7 [3.0-4.4]	^{Footnote #}	5.8 [4.9-6.8]	5.5^{Footnote ↓} [4.5-6.5]	5.8 [4.8-6.8]	^{Footnote #}
Grades 7-9	8.7 [7.3-10.0]	8.1 [5.7-10.6]	8.9 [7.3-10.5]	^{Footnote #}	8.0 [6.7-9.4]	7.4^{Footnote *} [4.9-9.9]	8.3 [6.7-9.9]	^{Footnote #}	2.4 [1.9-2.9]	^{Footnote #}	^{Footnote #}	^{Footnote #}	2.7 [2.0-3.4]	^{Footnote #}	^{Footnote #}	^{Footnote #}
Grades 10-12	30.4 [26.9-33.9]	30.7 [26.6-34.9]	30.0 [25.9-34.2]	^{Footnote #}	29.4 [25.9-33.0]	29.4 [25.3-33.6]	29.5^{Footnote ↓} [25.4-33.6]	^{Footnote #}	5.9 [5.1-6.8]	6.0 [4.9-7.1]	5.4 [4.2-6.6]	^{Footnote #}	8.7 [7.2-10.3]	8.3 [6.7-9.9]	8.8 [6.9-10.7]	^{Footnote #}
NS	23.0 [19.9-26.0]	22.4 [18.8-26.0]	24.1 [21.1-27.1]	17.2^{Footnote *} [10.9-23.5]	22.2 [19.4-24.9]	21.7 [18.4-25.1]	23.3 [20.4-26.2]	16.1^{Footnote *} [10.2-22.1]	5.3 [4.4-6.3]	5.5^{Footnote ↓} [4.3-6.6]	4.9 [3.8-6.1]	^{Footnote #}	7.9 [6.3-9.5]	7.3 [5.7-8.8]	8.2 [5.9-10.6]	^{Footnote #}
Grades 7-9	11.4 [9.3-13.6]	9.4 [7.3-11.4]	13.7 [10.4-17.1]	11.9 [8.6-15.3]	11.0 [8.9-13.1]	9.0 [7.1-10.9]	13.2 [9.9-16.5]	11.4 [8.1-14.7]	3.2 [2.5-3.8]	3.3 [2.4-4.1]	2.9 [2.0-3.8]	^{Footnote #}	3.9 [3.0-4.8]	3.0 [2.0-3.9]	4.9 [3.4-6.4]	^{Footnote #}
Grades 10-12	33.3 [28.6-38.1]	34.2 [27.8-40.6]	33.3 [29.1-37.5]	22.3^{Footnote *} [10.6-34.0]	32.3 [28.0-36.6]	33.3 [27.4-39.3]	32.3 [28.3-36.2]	^{Footnote #}	7.3 [5.9-8.8]	7.5^{Footnote ↑} [5.7-9.4]	6.8 [5.1-8.4]	^{Footnote #}	11.5^{Footnote ↑} [9.0-14.1]	11.3 [8.7-13.8]	11.2 [7.5-14.8]	^{Footnote #}
QC	19.5^{Footnote ↓} [14.2-24.8]	15.9 [11.2-20.6]	22.3 [16.1-28.5]	22.9 [16.5-29.4]	18.4 [13.2-23.6]	14.9 [10.3-19.5]	21.3 [15.2-27.3]	21.3 [15.5-27.1]	6.1 [4.4-7.8]	6.1 [4.2-7.9]	5.6 [3.9-7.2]	^{Footnote #}	6.5^{Footnote ↑} [4.8-8.3]	5.1^{Footnote *} [3.4-6.9]	7.3 [5.6-9.1]	9.5^{Footnote ↓} [6.8-12.2]
Secondary I-III	14.5^{Footnote ↑}^{Footnote *} [9.0-20.1]	11.2^{Footnote *} [6.6-15.8]	17.1^{Footnote *} [10.3-23.9]	17.6 [12.5-22.7]	13.5^{Footnote ↑} [8.2-18.8]	10.3^{Footnote *} [5.8-14.8]	16.1^{Footnote *} [9.5-22.6]	15.5^{Footnote ↓} [11.1-19.8]	5.4^{Footnote *} [3.4-7.4]	5.0^{Footnote *} [3.0-7.0]	5.3^{Footnote *} [3.1-7.5]	^{Footnote #}	5.4^{Footnote *} [3.3-7.5]	4.1^{Footnote *} [2.1-6.2]	6.1^{Footnote *} [3.8-8.4]	^{Footnote #}
Secondary IV-V	26.9 [21.5-32.4]	23.0 [17.8-28.1]	30.1 [24.0-36.2]	32.2 [22.2-42.3]	25.8 [20.3-31.2]	21.8 [16.8-26.9]	29.0 [22.9-35.2]	31.4 [21.6-41.2]	7.1 [5.9-8.4]	7.7 [5.6-9.7]	6.0 [4.8-7.1]	^{Footnote #}	8.3 [6.5-10.0]	6.7 [4.7-8.6]	9.1 [6.9-11.4]	^{Footnote #}
ON	15.3 [11.0-19.5]	13.6^{Footnote *} [7.8-19.3]	16.4 [11.4-21.4]	16.9 [11.9-21.8]	14.1 [9.8-18.4]	12.6^{Footnote *} [6.4-18.7]	15.4 [10.9-19.9]	13.1^{Footnote *} [6.0-20.3]	3.8 [2.7-4.9]	3.5^{Footnote ↑}^{Footnote *} [1.9-5.1]	3.5^{Footnote ↓} [2.7-4.2]	^{Footnote #}	4.6^{Footnote *} [2.8-6.4]	4.3^{Footnote *} [1.6-7.1]	4.5^{Footnote ↓}^{Footnote *} [2.8-6.1]	^{Footnote #}
Grades 7-9	8.5^{Footnote ↓} [5.9-11.1]	7.5^{Footnote ↑}^{Footnote *} [4.2-10.9]	8.8 [6.4-11.3]	^{Footnote #}	7.5^{Footnote ↑} [5.1-10.0]	7.0^{Footnote *} [3.6-10.3]	7.9 [5.5-10.3]	^{Footnote #}	2.7^{Footnote *} [1.7-3.7]	2.1^{Footnote *} [0.9-3.3]	2.6 [1.8-3.4]	^{Footnote #}	2.9^{Footnote *} [1.6-4.1]	^{Footnote #}	3.1^{Footnote *} [1.5-4.7]	^{Footnote #}
Grades 10-12	21.5^{Footnote ↓} [14.9-28.0]	19.5^{Footnote ↑} [11.1-27.9]	23.7^{Footnote *} [14.0-33.3]	^{Footnote #}	20.2^{Footnote *} [13.4-27.0]	18.1^{Footnote *} [8.9-27.3]	22.5^{Footnote ↑}^{Footnote *} [13.7-31.4]	^{Footnote #}	4.8 [3.4-6.2]	4.9^{Footnote *} [2.3-7.4]	4.3 [3.1-5.4]	^{Footnote #}	6.1^{Footnote *} [3.7-8.6]	6.5^{Footnote ↓}^{Footnote *} [2.3-10.6]	5.7^{Footnote *} [3.1-8.3]	^{Footnote #}
MB	16.7^{Footnote *} [10.3-23.0]	12.5^{Footnote ↑} [5.2-19.9]	19.5^{Footnote ↓} [10.9-28.1]	^{Footnote #}	14.9^{Footnote *} [9.0-20.9]	12.0^{Footnote *} [4.7-19.3]	16.5^{Footnote ↑}^{Footnote *} [10.7-22.4]	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
Grades 7-9	6.8^{Footnote *} [4.2-9.4]	4.1^{Footnote *} [2.3-5.9]	8.0^{Footnote *} [5.1-10.8]	^{Footnote #}	6.1^{Footnote *} [4.0-8.1]	3.7^{Footnote *} [2.2-5.1]	7.4^{Footnote *} [4.6-10.1]	^{Footnote #}	2.4^{Footnote *} [1.0-3.7]	^{Footnote #}	^{Footnote #}	^{Footnote #}	2.2^{Footnote *} [0.7-3.6]	^{Footnote #}	^{Footnote #}	^{Footnote #}
Grades 10-12	26.0^{Footnote *} [14.4-37.5]	^{Footnote #}	29.6^{Footnote *} [15.5-43.8]	^{Footnote #}	23.4^{Footnote *} [12.2-34.5]	^{Footnote #}	24.8^{Footnote *} [15.1-34.5]	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
SK	23.7 [20.9-26.5]	21.2 [17.6-24.7]	26.5^{Footnote ↑} [24.0-29.1]	21.1^{Footnote *} [13.9-28.3]	22.7 [20.1-25.3]	20.4 [17.0-23.8]	25.4 [22.9-27.8]	19.7^{Footnote *} [12.4-27.1]	5.3 [3.8-6.7]	5.1^{Footnote *} [3.4-6.8]	5.2 [3.6-6.8]	^{Footnote #}	6.4 [5.5-7.3]	5.4 [4.3-6.5]	7.1 [6.3-7.9]	^{Footnote #}
Grades 7-9	12.1 [9.9-14.2]	9.4 [7.2-11.6]	15.0 [12.3-17.8]	^{Footnote #}	10.8 [8.9-12.7]	8.4 [6.6-10.3]	13.6 [10.9-16.3]	^{Footnote #}	4.1 [3.0-5.2]	3.7^{Footnote *} [2.2-5.2]	4.5^{Footnote ↓} [3.2-5.7]	^{Footnote #}	4.1 [3.3-5.0]	3.0^{Footnote *} [2.0-4.1]	5.2 [4.2-6.3]	^{Footnote #}
Grades 10-12	35.0 [30.8-39.2]	32.7 [27.0-38.4]	37.6 [34.4-40.8]	^{Footnote #}	34.3 [30.2-38.3]	32.2 [26.4-37.9]	36.7 [33.6-39.8]	^{Footnote #}	6.4^{Footnote *} [4.3-8.5]	6.4^{Footnote *} [3.9-9.0]	5.9^{Footnote *} [3.6-8.2]	^{Footnote #}	8.7 [7.2-10.1]	7.7 [6.0-9.3]	8.9 [7.5-10.3]	^{Footnote #}
AB	14.8 [12.0-17.6]	12.9 [10.3-15.5]	16.2 [12.6-19.8]	18.4 [13.3-23.4]	13.8 [11.1-16.6]	12.1 [9.6-14.6]	15.2 [11.7-18.8]	^{Footnote #}	4.0 [3.2-4.7]	3.8 [3.0-4.5]	3.6 [2.7-4.4]	6.9^{Footnote *} [3.9-10.0]	4.3 [3.6-5.1]	3.8 [2.9-4.7]	4.4 [3.5-5.2]	6.7^{Footnote *} [3.7-9.7]
Grades 7-9	8.6 [6.9-10.3]	6.4 [4.6-8.1]	10.3 [8.0-12.5]	16.3^{Footnote *} [9.9-22.8]	7.7 [6.1-9.3]	5.5^{Footnote ↑} [3.9-7.1]	9.3 [7.1-11.5]	^{Footnote #}	2.9 [2.0-3.7]	2.3^{Footnote *} [1.2-3.4]	3.2^{Footnote *} [2.0-4.3]	^{Footnote #}	2.5^{Footnote ↑} [1.9-3.1]	1.9^{Footnote *} [1.1-2.7]	2.8 [1.9-3.7]	^{Footnote #}
Grades 10-12	20.7 [15.2-26.2]	19.3 [14.1-24.4]	21.7 [14.9-28.6]	20.7^{Footnote *} [12.8-28.6]	19.8 [14.4-25.1]	18.5^{Footnote ↓} [13.6-23.4]	20.8^{Footnote *} [13.9-27.7]	18.1^{Footnote *} [10.1-26.1]	5.0 [3.9-6.2]	5.2 [4.0-6.4]	3.9 [2.9-5.0]	^{Footnote #}	6.1 [4.7-7.6]	5.6 [3.9-7.3]	5.8 [4.4-7.3]	^{Footnote #}
BC	16.0^{Footnote *} [10.4-21.5]	14.1^{Footnote *} [8.2-19.9]	18.1^{Footnote *} [12.0-24.2]	12.5^{Footnote ↑}^{Footnote *} [6.5-18.5]	15.2^{Footnote *} [10.0-20.4]	13.5^{Footnote ↑} [8.0-19.1]	17.3^{Footnote *} [11.6-23.0]	10.6^{Footnote *} [5.6-15.7]	3.3^{Footnote *} [2.2-4.3]	2.9^{Footnote *} [1.8-4.1]	3.2^{Footnote *} [2.0-4.5]	^{Footnote #}	4.4^{Footnote *} [2.8-5.9]	3.3^{Footnote *} [1.8-4.8]	5.2 [3.6-6.8]	^{Footnote #}
Grades 7-9	8.6^{Footnote *} [5.5-11.7]	7.0^{Footnote *} [3.9-10.1]	9.8^{Footnote *} [6.5-13.0]	^{Footnote #}	7.9^{Footnote *} [5.0-10.8]	6.4^{Footnote *} [3.6-9.3]	9.2^{Footnote *} [6.0-12.4]	^{Footnote #}	2.3 [1.6-3.0]	1.9^{Footnote *} [0.9-2.8]	2.6 [1.8-3.3]	^{Footnote #}	2.8^{Footnote *} [1.6-4.0]	1.9^{Footnote *} [0.9-2.9]	3.5^{Footnote ↓}^{Footnote *} [2.0-4.9]	^{Footnote #}
Grades 10-12	23.0^{Footnote *} [13.8-32.2]	20.9^{Footnote *} [11.6-30.2]	25.8^{Footnote *} [15.0-36.6]	^{Footnote #}	22.2^{Footnote *} [13.5-30.9]	20.4^{Footnote *} [11.4-29.4]	24.8^{Footnote *} [14.7-34.9]	^{Footnote #}	4.2^{Footnote *} [2.3-6.1]	4.0^{Footnote *} [2.2-5.7]	3.8^{Footnote *} [1.4-6.2]	^{Footnote #}	6.0^{Footnote *} [3.6-8.4]	4.7^{Footnote *} [2.3-7.1]	6.9^{Footnote *} [4.4-9.3]	^{Footnote #}
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Use of e-cigarettes with nicotine, without nicotine, and/or with an unknown content. Return to footnote 3 referrer Footnote 4 Secondary I-III in Quebec. Return to footnote 4 referrer Footnote 5 Secondary IV-V in Quebec. Return to footnote 5 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote b High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to footnote # referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 7. Pattern of use of e-cigarettes in the past 30 days^{Footnote 1}, by nicotine content, grouped grades and gender, Canada^{Footnote 2}, 2021-22
	Never tried (%)	Tried, but did not use in the last 30 days (%)	Less than weekly, but at least once in the last 30 days (%)	Less than daily, but at least once a week (%)	Daily (%)
With nicotine
All grades (7-12)	73.7 [71.1-76.2]	10.6 [9.9-11.3]	4.1 [3.5-4.7]	3.5^{Footnote ↑} [3.0-4.1]	8.1 [6.3-9.9]
Man/boy	76.8 [73.8-79.8]	9.4 [8.5-10.4]	3.2 [2.7-3.8]	3.0 [2.3-3.7]	7.5^{Footnote ↑} [5.2-9.8]
Woman/girl	70.9 [68.0-73.7]	11.5^{Footnote ↑} [10.8-12.3]	5.2 [4.3-6.1]	4.0 [3.5-4.5]	8.4 [6.5-10.3]
Transgender, gender diverse, and/or questioning	73.4 [69.3-77.5]	11.5^{Footnote ↓} [9.4-13.5]	4.6 [3.7-5.5]	3.1^{Footnote *} [2.0-4.1]	7.5^{Footnote ↓}^{Footnote *} [4.7-10.3]
Grades 7-9^{Footnote 3}	84.5^{Footnote ↑} [82.4-86.6]	6.4 [5.6-7.1]	2.5^{Footnote ↓} [2.1-2.9]	2.2 [1.8-2.6]	4.5^{Footnote ↓} [3.4-5.6]
Man/boy	86.9 [84.7-89.2]	5.6 [4.8-6.4]	2.1 [1.7-2.5]	1.8 [1.4-2.3]	3.5^{Footnote ↑} [2.4-4.6]
Woman/girl	82.4 [80.1-84.7]	7.0 [6.0-8.0]	3.0 [2.4-3.5]	2.5^{Footnote ↑} [2.0-3.0]	5.1 [3.8-6.4]
Transgender, gender diverse, and/or questioning	80.1 [76.2-84.1]	8.7 [6.1-11.2]	2.7^{Footnote *} [1.8-3.6]	2.7^{Footnote *} [1.5-3.9]	5.8^{Footnote *} [3.7-8.0]
Grades 10-12^{Footnote 4}	62.6 [58.8-66.4]	15.0 [13.8-16.2]	5.8 [4.8-6.8]	4.9 [4.0-5.8]	11.8 [8.9-14.6]
Man/boy	66.1 [61.7-70.4]	13.5^{Footnote ↓} [11.4-15.5]	4.4 [3.5-5.3]	4.3 [3.0-5.6]	11.7^{Footnote *} [7.9-15.6]
Woman/girl	59.0 [54.2-63.9]	16.2 [14.8-17.6]	7.4 [5.8-9.1]	5.5^{Footnote ↓} [4.5-6.4]	11.9 [8.9-14.9]
Transgender, gender diverse, and/or questioning	65.5^{Footnote ↓} [60.2-70.7]	14.8 [11.6-18.0]	6.8 [5.3-8.4]	3.5^{Footnote ↑}^{Footnote *} [1.9-5.1]	9.5^{Footnote ↓}^{Footnote *} [5.1-13.8]
Without nicotine
All grades (7-12)	83.6 [82.0-85.2]	12.1 [10.9-13.2]	2.1 [1.8-2.4]	1.1 [0.9-1.3]	1.1 [0.8-1.5]
Man/boy	84.7 [82.8-86.6]	11.2 [9.8-12.6]	2.0 [1.5-2.5]	1.0 [0.8-1.3]	1.1^{Footnote *} [0.7-1.4]
Woman/girl	82.9 [81.1-84.8]	13.0 [11.6-14.5]	2.0 [1.7-2.3]	1.1 [0.9-1.3]	0.9^{Footnote *} [0.5-1.3]
Transgender, gender diverse, and/or questioning	82.4 [80.3-84.6]	11.3 [9.3-13.4]	3.9^{Footnote *} [1.9-5.8]	1.1^{Footnote *} [0.4-1.7]	1.3^{Footnote *} [0.8-1.8]
Grades 7-9	90.6 [89.1-92.1]	6.1 [5.2-7.0]	1.6 [1.3-1.9]	0.9 [0.6-1.1]	0.8 [0.6-1.1]
Man/boy	91.8 [90.3-93.3]	5.4 [4.5-6.3]	1.3 [1.0-1.6]	0.7 [0.5-0.9]	0.9^{Footnote *} [0.5-1.2]
Woman/girl	89.9 [88.2-91.6]	6.8 [5.6-7.9]	1.7 [1.4-2.1]	1.0 [0.7-1.3]	0.6 [0.4-0.8]
Transgender, gender diverse, and/or questioning	85.8 [82.1-89.5]	8.4 [5.8-11.0]	^{Footnote #}	^{Footnote #}	^{Footnote #}
Grades 10-12	76.5^{Footnote ↓} [74.2-78.7]	18.2 [16.3-20.1]	2.5^{Footnote ↑} [2.1-3.0]	1.4 [1.1-1.6]	1.5^{Footnote ↓}^{Footnote *} [0.9-2.0]
Man/boy	77.1 [74.3-80.0]	17.4 [14.9-19.9]	2.7^{Footnote *} [1.7-3.6]	1.5^{Footnote ↓} [1.1-1.8]	1.3^{Footnote *} [0.8-1.8]
Woman/girl	75.8 [72.9-78.7]	19.5^{Footnote ↑} [17.1-22.0]	2.3 [1.7-2.9]	1.2 [0.9-1.5]	^{Footnote #}
Transgender, gender diverse, and/or questioning	78.5^{Footnote ↑} [75.3-81.8]	14.8 [11.5-18.1]	3.9^{Footnote *} [1.9-6.0]	^{Footnote #}	^{Footnote #}
Did not know what it contained
All grades (7-12)	87.3 [85.8-88.7]	7.7 [7.0-8.3]	2.0 [1.7-2.2]	1.4 [1.0-1.8]	1.7 [1.2-2.2]
Man/boy	89.5^{Footnote ↑} [87.9-91.2]	6.1 [5.4-6.9]	1.5^{Footnote ↓} [1.2-1.7]	1.3^{Footnote *} [0.7-1.8]	1.6^{Footnote *} [0.9-2.2]
Woman/girl	85.5^{Footnote ↑} [83.9-87.1]	9.1 [8.2-10.1]	2.4 [2.0-2.9]	1.6 [1.2-2.0]	1.3 [1.0-1.7]
Transgender, gender diverse, and/or questioning	84.4 [82.2-86.6]	9.7 [7.7-11.7]	2.8 [1.9-3.6]	1.3^{Footnote *} [0.7-1.9]	1.8^{Footnote *} [1.1-2.6]
Grades 7-9	92.2 [91.0-93.4]	4.4 [3.8-4.9]	1.2 [1.0-1.5]	1.0 [0.7-1.2]	1.2^{Footnote *} [0.7-1.7]
Man/boy	94.0 [92.8-95.3]	3.4 [2.7-4.1]	0.8 [0.5-1.0]	0.7^{Footnote *} [0.5-1.0]	1.0^{Footnote *} [0.6-1.5]
Woman/girl	91.0 [89.8-92.2]	5.0 [4.3-5.7]	1.7 [1.2-2.2]	1.1 [0.8-1.4]	1.1^{Footnote *} [0.5-1.8]
Transgender, gender diverse, and/or questioning	86.4 [83.0-89.8]	8.5^{Footnote ↑}^{Footnote *} [5.0-12.1]	2.0^{Footnote *} [1.0-3.1]	^{Footnote #}	^{Footnote #}
Grades 10-12	82.2 [80.1-84.3]	11.1 [10.0-12.2]	2.7 [2.3-3.1]	1.9^{Footnote *} [1.1-2.6]	2.1 [1.6-2.7]
Man/boy	84.8 [82.3-87.2]	9.0 [7.6-10.5]	2.2 [1.9-2.6]	1.8^{Footnote *} [0.9-2.7]	2.2^{Footnote *} [1.2-3.1]
Woman/girl	79.8 [76.8-82.8]	13.4 [11.3-15.5]	3.2 [2.5-3.9]	2.1^{Footnote *} [1.2-2.9]	1.5^{Footnote ↑} [1.2-1.9]
Transgender, gender diverse, and/or questioning	82.1 [78.6-85.6]	11.1 [8.1-14.1]	3.6^{Footnote *} [2.3-4.9]	^{Footnote #}	^{Footnote #}
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Secondary I-III in Quebec. Return to footnote 3 referrer Footnote 4 Secondary IV-V in Quebec. Return to footnote 4 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote b High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to footnote # referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Estimates may not sum to 100 percent due to rounding. Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 8. Perceived risk of harm from using cigarettes and e-cigarettes^{Footnote 1}, Canada^{Footnote 2}, 2021-22
	Smoking cigarettes once in a while (%)	Smoking cigarettes on a regular basis (%)	Using e-cigarettes with nicotine once in a while (%)	Using e-cigarettes with nicotine on a regular basis (%)	Using e-cigarettes without nicotine once in a while (%)	Using e-cigarettes without nicotine on a regular basis (%)
No risk	13.1 [12.1-14.1]	6.3 [5.5-7.2]	12.3 [11.3-13.3]	6.6 [5.8-7.5]	24.2 [23.0-25.3]	13.3 [12.4-14.2]
Slight risk	41.3 [39.1-43.4]	4.0 [3.6-4.4]	32.6 [30.5-34.6]	7.7 [7.1-8.2]	36.3 [34.9-37.8]	23.3 [22.2-24.4]
Moderate risk	30.2 [28.8-31.6]	24.0 [22.4-25.6]	31.8 [30.4-33.1]	28.2 [27.0-29.4]	17.6 [16.9-18.3]	30.0 [28.9-31.1]
Great risk	9.8 [8.7-10.8]	60.3 [58.7-61.9]	14.1 [13.1-15.2]	48.2 [46.9-49.5]	9.5^{Footnote ↓} [8.6-10.4]	20.6 [19.6-21.7]
Don't know	5.6 [4.9-6.2]	5.4 [4.7-6.0]	9.2 [8.5-10.0]	9.3 [8.5-10.1]	12.4 [11.6-13.2]	12.8 [12.1-13.5]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Estimates may not sum to 100 percent due to rounding. Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 9. Ever tried a tobacco product^{Footnote 1}, by grouped grades and gender, Canada^{Footnote 2}, 2021-22
	Any tobacco product^{Footnote 3} (%)	Cigarettes^{Footnote 4} (%)	Cigars/cigarillos/little cigars (%)	Heated tobacco products (%)	Smokeless tobacco (%)	Waterpipe (%)
All grades (7-12)	18.6 [16.8-20.4]	15.3 [13.3-17.2]	7.3 [6.2-8.4]	2.8 [2.4-3.1]	4.3 [3.5-5.0]	4.9 [4.3-5.5]
Man/boy	17.9 [15.5-20.2]	14.2 [11.8-16.6]	8.5^{Footnote ↑} [6.8-10.2]	2.5^{Footnote ↓} [2.0-2.9]	5.2 [3.9-6.6]	4.8 [4.0-5.5]
Woman/girl	18.3 [16.5-20.1]	15.6 [13.7-17.5]	5.6 [4.7-6.6]	2.5^{Footnote ↑} [2.1-2.9]	2.9 [2.5-3.3]	4.5^{Footnote ↑} [3.8-5.2]
Transgender, gender diverse, and/or questioning	25.4 [22.0-28.9]	23.0 [19.6-26.4]	7.7 [6.1-9.2]	4.2 [2.8-5.5]	4.3 [3.4-5.3]	6.2^{Footnote *} [4.0-8.4]
Grades 7-9^{Footnote 5}	11.1 [9.6-12.6]	9.1 [7.7-10.5]	3.4 [2.7-4.1]	1.9 [1.5-2.4]	2.3 [1.7-2.8]	2.8 [2.2-3.4]
Man/boy	10.0 [8.3-11.7]	7.9 [6.4-9.5]	3.1 [2.4-3.9]	1.7 [1.2-2.2]	2.1 [1.5-2.6]	2.3 [1.7-2.8]
Woman/girl	11.2 [9.7-12.7]	9.3 [7.9-10.7]	3.2 [2.2-4.2]	1.8 [1.4-2.2]	2.2 [1.5-2.8]	3.0 [2.3-3.8]
Transgender, gender diverse, and/or questioning	19.8 [16.4-23.3]	17.7 [14.5-20.8]	6.2 [4.4-8.0]	3.9^{Footnote *} [2.1-5.7]	3.2^{Footnote *} [2.2-4.3]	4.3 [2.9-5.7]
Grades 10-12^{Footnote 6}	26.3 [23.5-29.0]	21.6 [18.5-24.7]	11.3 [9.6-13.0]	3.6 [2.9-4.3]	6.3 [5.1-7.5]	7.1 [6.2-8.0]
Man/boy	26.2 [22.6-29.9]	20.9 [17.3-24.5]	14.2 [11.2-17.2]	3.3 [2.5-4.2]	8.6 [6.2-11.0]	7.4 [6.3-8.6]
Woman/girl	25.7 [22.4-29.0]	22.1 [18.5-25.7]	8.2 [7.0-9.4]	3.3 [2.6-4.0]	3.6 [3.0-4.3]	6.0 [5.1-7.0]
Transgender, gender diverse, and/or questioning	32.0 [26.7-37.3]	29.4 [23.9-34.8]	9.3 [6.9-11.7]	4.4^{Footnote *} [2.6-6.3]	5.6 [4.0-7.3]	8.4^{Footnote *} [5.0-11.9]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 "Any tobacco product" includes lifetime use of cigarettes, cigars, little cigars or cigarillos, heated tobacco products, smokeless tobacco, and waterpipe tobacco. E-cigarettes are excluded. Return to footnote 3 referrer Footnote 4 Ever tried, even just a few puffs. Return to footnote 4 referrer Footnote 5 Secondary I-III in Quebec. Return to footnote 5 referrer Footnote 6 Secondary IV-V in Quebec. Return to footnote 6 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 10. Past-30-day use of a tobacco product^{Footnote 1}, by grouped grades and gender, Canada^{Footnote 2}, 2021-22
	Any tobacco product^{Footnote 3} (%)	Cigarettes^{Footnote 4} (%)	Cigars/cigarillos/little cigars (%)	Heated tobacco products (%)	Smokeless tobacco (%)	Waterpipe (%)
All grades (7-12)	6.2 [5.0-7.3]	4.1 [3.1-5.1]	2.1 [1.5-2.8]	1.3 [1.0-1.6]	1.3 [1.0-1.5]	1.6 [1.3-1.9]
Man/boy	6.1 [4.6-7.7]	3.9 [2.6-5.1]	2.7^{Footnote *} [1.6-3.9]	1.2 [0.9-1.4]	1.5^{Footnote ↑} [1.1-2.0]	1.6 [1.2-2.0]
Woman/girl	5.4 [4.4-6.4]	3.7 [2.9-4.6]	1.0 [0.8-1.3]	1.0 [0.7-1.3]	0.6 [0.4-0.8]	1.2 [0.9-1.4]
Transgender, gender diverse, and/or questioning	10.8 [7.6-13.9]	8.4^{Footnote *} [5.2-11.5]	3.0^{Footnote *} [2.0-4.0]	2.1^{Footnote *} [1.0-3.2]	1.8^{Footnote *} [1.0-2.6]	2.1^{Footnote *} [1.3-3.0]
Grades 7-9^{Footnote 5}	3.6 [2.8-4.4]	2.3 [1.7-2.8]	1.2 [1.0-1.5]	1.0 [0.7-1.3]	0.9 [0.6-1.1]	1.2^{Footnote *} [0.8-1.7]
Man/boy	3.1 [2.2-4.0]	2.0^{Footnote *} [1.3-2.7]	1.2 [0.8-1.6]	0.9 [0.6-1.1]	0.9^{Footnote *} [0.5-1.2]	1.0^{Footnote *} [0.5-1.5]
Woman/girl	3.4 [2.6-4.2]	2.0^{Footnote *} [1.3-2.6]	0.8 [0.6-1.1]	0.8^{Footnote *} [0.4-1.2]	0.5^{Footnote ↑}^{Footnote *} [0.3-0.8]	1.1^{Footnote *} [0.7-1.5]
Transgender, gender diverse, and/or questioning	8.3 [5.9-10.7]	5.8 [4.0-7.6]	2.9^{Footnote *} [1.9-3.8]	^{Footnote #}	^{Footnote #}	1.9^{Footnote *} [1.2-2.7]
Grades 10-12^{Footnote 6}	8.8 [6.9-10.7]	6.0 [4.3-7.7]	3.1^{Footnote *} [2.0-4.2]	1.6 [1.2-2.1]	1.7 [1.3-2.1]	2.0 [1.5-2.5]
Man/boy	9.4 [6.9-12.0]	5.9^{Footnote *} [3.9-7.9]	4.4^{Footnote *} [2.4-6.4]	1.5^{Footnote ↑} [1.1-2.0]	2.2 [1.5-2.9]	2.1 [1.6-2.6]
Woman/girl	7.4 [5.5-9.2]	5.5^{Footnote ↑} [3.9-7.2]	1.2^{Footnote *} [0.8-1.7]	1.2^{Footnote *} [0.8-1.6]	0.7^{Footnote *} [0.4-0.9]	1.2^{Footnote *} [0.8-1.6]
Transgender, gender diverse, and/or questioning	13.7^{Footnote *} [8.9-18.5]	11.4^{Footnote *} [6.4-16.4]	3.1^{Footnote *} [1.3-5.0]	^{Footnote #}	^{Footnote #}	2.4^{Footnote *} [0.9-3.9]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 "Any tobacco product" includes past-30-day use of cigarettes, cigars, little cigars or cigarillos, heated tobacco products, smokeless tobacco, and waterpipe tobacco. E-cigarettes are excluded. Return to footnote 3 referrer Footnote 4 Smoked one or more cigarettes in the past 30 days. Return to footnote 4 referrer Footnote 5 Secondary I-III in Quebec. Return to footnote 5 referrer Footnote 6 Secondary IV-V in Quebec. Return to footnote 6 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote b High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to footnote # referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 11. Past-30-day use of cigarettes, e-cigarettes, any tobacco product^{Footnote 1}, by province, gender and grouped grades, Canada^{Footnote 2}, 2021-22
	Cigarettes^{Footnote 3} (%)	E-cigarettes^{Footnote 4} (%)	E-cigarettes with nicotine (%)	E-cigarettes without nicotine (%)	Any tobacco product^{Footnote 5} (%)
Canada^{Footnote 2}	4.1 [3.1-5.1]	16.8 [14.5-19.1]	15.7 [13.4-18.0]	4.3 [3.7-5.0]	6.2 [5.0-7.3]
Man/boy	3.9 [2.6-5.1]	14.6 [11.9-17.4]	13.7 [10.9-16.6]	4.1 [3.2-4.9]	6.1 [4.6-7.7]
Woman/girl	3.7 [2.9-4.6]	18.6 [16.1-21.2]	17.6 [15.2-19.9]	4.0 [3.5-4.5]	5.4 [4.4-6.4]
Transgender, gender diverse, and/or questioning	8.4^{Footnote *} [5.2-11.5]	17.8 [15.3-20.2]	15.1 [12.0-18.2]	6.2^{Footnote *} [4.1-8.3]	10.8 [7.6-13.9]
Grades 7-9^{Footnote 6}	2.3 [1.7-2.8]	10.1 [8.4-11.7]	9.1 [7.5-10.7]	3.3 [2.7-4.0]	3.6 [2.8-4.4]
Grades 10-12^{Footnote 7}	6.0 [4.3-7.7]	23.6 [20.2-27.1]	22.4 [18.9-26.0]	5.4 [4.5-6.3]	8.8 [6.9-10.7]
NL	5.3 [4.4-6.2]	26.6 [25.0-28.3]	25.6 [23.9-27.4]	5.7 [5.1-6.3]	7.4 [6.2-8.6]
Man/boy	6.2 [5.0-7.5]	24.9 [23.1-26.7]	23.8 [21.9-25.7]	6.1 [5.3-6.9]	8.7 [7.2-10.2]
Woman/girl	3.9 [3.3-4.6]	28.9 [27.0-30.8]	27.9 [26.0-29.8]	5.1 [4.3-5.8]	5.5^{Footnote ↓} [4.7-6.3]
Transgender, gender diverse, and/or questioning	^{Footnote #}	21.0 [16.5-25.4]	20.6 [16.2-25.0]	^{Footnote #}	^{Footnote #}
Grades 7-9	2.9 [2.1-3.7]	15.3 [13.2-17.3]	14.4 [12.4-16.4]	3.5^{Footnote ↑} [2.8-4.2]	4.0 [3.1-4.9]
Grades 10-12	8.1 [6.4-9.9]	39.5^{Footnote ↓} [36.6-42.4]	38.3 [35.3-41.3]	8.2 [7.3-9.2]	11.3 [9.1-13.6]
PE	5.1 [4.1-6.2]	20.0 [18.1-22.0]	19.2 [17.2-21.2]	4.2 [3.8-4.7]	7.5^{Footnote ↓} [6.3-8.6]
Man/boy	6.0 [4.6-7.3]	20.2 [17.8-22.6]	19.1 [16.7-21.5]	4.4 [3.7-5.0]	9.0 [7.3-10.7]
Woman/girl	3.7 [2.7-4.6]	20.0 [17.7-22.2]	19.4 [17.2-21.6]	3.7 [3.0-4.4]	5.1 [4.2-6.0]
Transgender, gender diverse, and/or questioning	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
Grades 7-9	2.4 [1.7-3.1]	8.7 [7.3-10.0]	8.0 [6.7-9.4]	2.4 [1.9-2.9]	3.1 [2.4-3.9]
Grades 10-12	7.7 [5.8-9.6]	30.4 [26.9-33.9]	29.4 [25.9-33.0]	5.9 [5.1-6.8]	11.4 [9.4-13.5]
NS	5.6 [4.2-7.1]	23.0 [19.9-26.0]	22.2 [19.4-24.9]	5.3 [4.4-6.3]	8.2 [6.6-9.8]
Man/boy	5.8 [4.3-7.3]	22.4 [18.8-26.0]	21.7 [18.4-25.1]	5.5^{Footnote ↓} [4.3-6.6]	9.3 [7.3-11.3]
Woman/girl	4.8^{Footnote *} [3.2-6.4]	24.1 [21.1-27.1]	23.3 [20.4-26.2]	4.9 [3.8-6.1]	6.5^{Footnote ↓} [5.0-7.9]
Transgender, gender diverse, and/or questioning	^{Footnote #}	17.2^{Footnote *} [10.9-23.5]	16.1^{Footnote *} [10.2-22.1]	^{Footnote #}	^{Footnote #}
Grades 7-9	3.3 [2.4-4.2]	11.4 [9.3-13.6]	11.0 [8.9-13.1]	3.2 [2.5-3.8]	4.4 [3.5-5.3]
Grades 10-12	7.7 [5.5-10.0]	33.3 [28.6-38.1]	32.3 [28.0-36.6]	7.3 [5.9-8.8]	11.7 [9.2-14.1]
QC	2.7 [1.9-3.6]	19.5^{Footnote ↓} [14.2-24.8]	18.4 [13.2-23.6]	6.1 [4.4-7.8]	5.7 [4.1-7.2]
Man/boy	2.6 [1.8-3.4]	15.9 [11.2-20.6]	14.9 [10.3-19.5]	6.1 [4.2-7.9]	5.7 [3.9-7.5]
Woman/girl	2.1^{Footnote *} [1.3-3.0]	22.3 [16.1-28.5]	21.3 [15.2-27.3]	5.6 [3.9-7.2]	4.5^{Footnote ↓} [3.2-5.8]
Transgender, gender diverse, and/or questioning	^{Footnote #}	22.9 [16.5-29.4]	21.3 [15.5-27.1]	^{Footnote #}	12.3 [8.8-15.8]
Secondary I-III	1.9^{Footnote *} [1.1-2.7]	14.5^{Footnote ↑}^{Footnote *} [9.0-20.1]	13.5^{Footnote ↑}^{Footnote *} [8.2-18.8]	5.4^{Footnote *} [3.4-7.4]	3.8^{Footnote *} [2.3-5.3]
Secondary IV-V	3.9 [2.8-5.1]	26.9 [21.5-32.4]	25.8 [20.3-31.2]	7.1 [5.9-8.4]	8.4 [6.5-10.3]
ON	4.4^{Footnote *} [2.3-6.5]	15.3 [11.0-19.5]	14.1 [9.8-18.4]	3.8 [2.7-4.9]	6.0^{Footnote *} [3.6-8.5]
Man/boy	^{Footnote #}	13.6^{Footnote *} [7.8-19.3]	12.6^{Footnote *} [6.4-18.7]	3.5^{Footnote ↑}^{Footnote *} [1.9-5.1]	6.1^{Footnote *} [2.6-9.7]
Woman/girl	4.1^{Footnote *} [2.3-6.0]	16.4 [11.4-21.4]	15.4 [10.9-19.9]	3.5^{Footnote ↓} [2.7-4.2]	5.2^{Footnote *} [3.1-7.3]
Transgender, gender diverse, and/or questioning	^{Footnote #}	16.9 [11.9-21.8]	13.1^{Footnote *} [6.0-20.3]	^{Footnote #}	12.3^{Footnote *} [5.8-18.7]
Grades 7-9	2.5^{Footnote ↓}^{Footnote *} [1.2-3.7]	8.5^{Footnote ↓} [5.9-11.1]	7.5^{Footnote ↑} [5.1-10.0]	2.7^{Footnote *} [1.7-3.7]	3.6^{Footnote *} [2.0-5.2]
Grades 10-12	6.2^{Footnote *} [2.7-9.7]	21.5^{Footnote ↓} [14.9-28.0]	20.2^{Footnote *} [13.4-27.0]	4.8 [3.4-6.2]	8.2^{Footnote *} [4.4-12.1]
MB	^{Footnote #}	16.7^{Footnote *} [10.3-23.0]	14.9^{Footnote *} [9.0-20.9]	^{Footnote #}	6.2^{Footnote *} [2.4-10.1]
Man/boy	^{Footnote #}	12.5^{Footnote ↑}^{Footnote *} [5.2-19.9]	12.0^{Footnote *} [4.7-19.3]	^{Footnote #}	^{Footnote #}
Woman/girl	^{Footnote #}	19.5^{Footnote ↓}^{Footnote *} [10.9-28.1]	16.5^{Footnote ↑}^{Footnote *} [10.7-22.4]	^{Footnote #}	^{Footnote #}
Transgender, gender diverse, and/or questioning	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
Grades 7-9	^{Footnote #}	6.8^{Footnote *} [4.2-9.4]	6.1^{Footnote *} [4.0-8.1]	2.4^{Footnote *} [1.0-3.7]	2.5^{Footnote ↑}^{Footnote *} [1.0-4.0]
Grades 10-12	^{Footnote #}	26.0^{Footnote *} [14.4-37.5]	23.4^{Footnote *} [12.2-34.5]	^{Footnote #}	^{Footnote #}
SK	8.1^{Footnote *} [4.1-12.1]	23.7 [20.9-26.5]	22.7 [20.1-25.3]	5.3 [3.8-6.7]	10.3^{Footnote *} [6.5-14.2]
Man/boy	7.6^{Footnote *} [4.5-10.7]	21.2 [17.6-24.7]	20.4 [17.0-23.8]	5.1^{Footnote *} [3.4-6.8]	10.1 [7.3-12.9]
Woman/girl	8.2^{Footnote *} [3.1-13.4]	26.5^{Footnote ↑} [24.0-29.1]	25.4 [22.9-27.8]	5.2 [3.6-6.8]	10.0^{Footnote *} [4.9-15.1]
Transgender, gender diverse, and/or questioning	^{Footnote #}	21.1^{Footnote *} [13.9-28.3]	19.7^{Footnote *} [12.4-27.1]	^{Footnote #}	^{Footnote #}
Grades 7-9	3.3^{Footnote *} [1.8-4.7]	12.1 [9.9-14.2]	10.8 [8.9-12.7]	4.1 [3.0-5.2]	4.5^{Footnote ↑}^{Footnote *} [2.9-6.1]
Grades 10-12	12.9^{Footnote *} [5.9-20.0]	35.0 [30.8-39.2]	34.3 [30.2-38.3]	6.4^{Footnote *} [4.3-8.5]	16.1^{Footnote *} [9.3-22.9]
AB	3.4 [2.7-4.2]	14.8 [12.0-17.6]	13.8 [11.1-16.6]	4.0 [3.2-4.7]	5.7 [4.6-6.7]
Man/boy	3.5^{Footnote ↑} [2.5-4.5]	12.9 [10.3-15.5]	12.1 [9.6-14.6]	3.8 [3.0-4.5]	5.7 [4.5-7.0]
Woman/girl	2.7 [1.9-3.4]	16.2 [12.6-19.8]	15.2 [11.7-18.8]	3.6 [2.7-4.4]	4.9 [3.9-5.9]
Transgender, gender diverse, and/or questioning	^{Footnote #}	18.4 [13.3-23.4]	16.5^{Footnote ↓} [11.1-21.8]	6.9^{Footnote *} [3.9-10.0]	9.3^{Footnote *} [5.7-13.0]
Grades 7-9	2.2^{Footnote *} [1.3-3.1]	8.6 [6.9-10.3]	7.7 [6.1-9.3]	2.9 [2.0-3.7]	3.4 [2.4-4.5]
Grades 10-12	4.6 [3.3-5.9]	20.7 [15.2-26.2]	19.8 [14.4-25.1]	5.0 [3.9-6.2]	7.9 [6.1-9.7]
BC	4.0^{Footnote *} [2.3-5.8]	16.0^{Footnote *} [10.4-21.5]	15.2^{Footnote *} [10.0-20.4]	3.3^{Footnote *} [2.2-4.3]	6.2^{Footnote *} [3.8-8.5]
Man/boy	3.4^{Footnote *} [1.4-5.4]	14.1^{Footnote *} [8.2-19.9]	13.5^{Footnote ↑}^{Footnote *} [8.0-19.1]	2.9^{Footnote *} [1.8-4.1]	5.7^{Footnote *} [3.2-8.2]
Woman/girl	4.3^{Footnote *} [2.4-6.2]	18.1^{Footnote *} [12.0-24.2]	17.3^{Footnote *} [11.6-23.0]	3.2^{Footnote *} [2.0-4.5]	6.1^{Footnote *} [3.5-8.7]
Transgender, gender diverse, and/or questioning	^{Footnote #}	12.5^{Footnote ↑}^{Footnote *} [6.5-18.5]	10.6^{Footnote *} [5.6-15.7]	^{Footnote #}	^{Footnote #}
Grades 7-9	2.0^{Footnote *} [0.7-3.2]	8.6^{Footnote *} [5.5-11.7]	7.9^{Footnote *} [5.0-10.8]	2.3 [1.6-3.0]	3.3^{Footnote *} [1.6-5.0]
Grades 10-12	6.1^{Footnote *} [3.4-8.8]	23.0^{Footnote *} [13.8-32.2]	22.2^{Footnote *} [13.5-30.9]	4.2^{Footnote *} [2.3-6.1]	9.0^{Footnote *} [5.4-12.5]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Smoked one or more cigarettes in the past 30 days. Return to footnote 3 referrer Footnote 4 Use of e-cigarettes with nicotine, without nicotine, and/or with an unknown content. Return to footnote 4 referrer Footnote 5 "Any tobacco product" includes past-30-day use of cigarettes, cigars, little cigars or cigarillos, heated tobacco products, smokeless tobacco, and waterpipe tobacco. E-cigarettes are excluded. Return to footnote 5 referrer Footnote 6 Secondary I-III in Quebec. Return to footnote 6 referrer Footnote 7 Secondary IV-V in Quebec. Return to footnote 7 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote b High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to footnote # referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 12. Main reason for currently/continued vaping among students who vaped with nicotine in the past 30 days^{Footnote 1}, by province, Canada^{Footnote 2}, 2021-22
	Just to give it a try/to see what it's like (%)	Like the flavours (%)	To have a good time with my friends (%)	Peer pressure (%)	Using them instead of smoking cigarettes (%)	Trying to quit cigarettes (%)	Enjoy them (%)	Addicted to them (%)	To relax or relieve tension (%)	To feel good/to get a nicotine high (%)	Other reasons (%)
Canada^{Footnote 2}	8.1 [7.1-9.0]	7.4 [5.7-9.2]	9.1 [7.5-10.7]	1.0 [0.7-1.3]	2.0^{Footnote *} [1.4-2.7]	1.0^{Footnote *} [0.5-1.5]	13.6 [12.6-14.5]	19.8 [17.2-22.3]	20.4 [17.3-23.5]	12.0 [10.7-13.2]	5.7 [4.8-6.6]
NL	8.6 [7.3-9.8]	6.0 [5.0-6.9]	6.4 [5.1-7.8]	^{Footnote #}	3.3 [2.3-4.2]	^{Footnote #}	11.5^{Footnote ↑} [10.1-13.0]	23.5^{Footnote ↓} [21.1-25.9]	24.4 [22.0-26.8]	7.6 [6.4-8.8]	6.5^{Footnote ↓} [5.4-7.6]
PE	7.1 [6.1-8.1]	4.6 [3.4-5.8]	13.6 [10.2-17.0]	^{Footnote #}	^{Footnote #}	^{Footnote #}	12.3 [9.4-15.3]	20.3 [17.7-22.8]	16.8 [14.3-19.4]	14.1 [11.9-16.3]	6.1 [4.6-7.7]
NS	5.3 [4.1-6.5]	6.1^{Footnote *} [3.9-8.3]	6.0^{Footnote *} [3.7-8.4]	^{Footnote #}	^{Footnote #}	^{Footnote #}	13.6 [10.5-16.6]	28.4 [26.5-30.4]	17.9 [15.0-20.8]	11.2 [8.4-13.9]	6.9^{Footnote *} [4.4-9.4]
QC	10.1 [8.5-11.7]	9.3 [7.6-11.0]	10.4 [7.1-13.8]	^{Footnote #}	^{Footnote #}	^{Footnote #}	17.6 [15.6-19.6]	18.4 [14.6-22.3]	14.2 [10.9-17.5]	9.6 [8.6-10.7]	7.5^{Footnote ↓} [6.5-8.4]
ON	7.8 [5.7-10.0]	6.8^{Footnote *} [2.7-10.9]	8.6^{Footnote *} [5.1-12.0]	^{Footnote #}	^{Footnote #}	^{Footnote #}	12.6 [11.0-14.2]	20.9 [15.3-26.6]	22.6 [15.5-29.6]	12.7 [10.4-15.0]	4.5^{Footnote ↓}^{Footnote *} [2.6-6.3]
MB	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	12.2^{Footnote *} [4.3-20.1]	^{Footnote #}	25.9^{Footnote *} [9.1-42.7]	^{Footnote #}	^{Footnote #}
SK	8.3 [6.5-10.1]	7.6 [6.0-9.2]	9.2 [7.0-11.4]	^{Footnote #}	^{Footnote #}	^{Footnote #}	12.5^{Footnote ↓} [10.2-14.7]	19.0 [15.7-22.2]	21.1 [18.6-23.6]	10.6 [8.5-12.7]	5.7 [4.2-7.2]
AB	7.0 [5.9-8.1]	7.8 [5.5-10.1]	7.5^{Footnote ↑} [6.2-8.9]	^{Footnote #}	2.9 [2.0-3.8]	^{Footnote #}	11.5^{Footnote ↑} [10.0-13.1]	17.5^{Footnote ↑} [15.3-19.7]	25.5^{Footnote ↑} [22.3-28.8]	11.8 [9.4-14.2]	6.2 [4.7-7.7]
BC	7.3 [5.9-8.6]	6.8^{Footnote *} [4.1-9.4]	10.6 [8.4-12.9]	^{Footnote #}	^{Footnote #}	^{Footnote #}	13.0 [10.2-15.7]	18.2 [14.2-22.2]	17.6 [14.1-21.2]	16.3 [11.9-20.7]	5.4 [4.4-6.5]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote b High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to footnote # referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Estimates may not sum to 100 percent due to rounding. Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 13. Flavour vaped most often among students who vaped with nicotine in the past 30 days^{Footnote 1}, by province, Canada^{Footnote 2}, 2021-22
	Tobacco (%)	Fruit (%)	Candy (%)	Dessert (%)	Mint/menthol (%)	Coffee/tea (%)	Alcohol (%)	Flavourless (%)	No usual flavour (%)
Canada^{Footnote 2}	2.4^{Footnote *} [1.3-3.4]	62.7 [59.3-66.1]	4.8 [3.8-5.8]	0.6^{Footnote *} [0.3-0.9]	11.3 [8.6-14.0]	0.5^{Footnote ↑}^{Footnote *} [0.3-0.8]	0.7^{Footnote *} [0.4-1.0]	0.4^{Footnote *} [0.3-0.6]	16.6 [14.9-18.2]
NL	^{Footnote #}	49.8 [46.4-53.2]	10.5^{Footnote ↑} [9.0-12.1]	^{Footnote #}	13.9 [10.3-17.5]	^{Footnote #}	^{Footnote #}	^{Footnote #}	21.7 [19.1-24.4]
PE	^{Footnote #}	50.4 [47.1-53.8]	4.8 [3.6-6.1]	^{Footnote #}	8.9 [6.6-11.2]	^{Footnote #}	^{Footnote #}	5.2 [3.8-6.7]	26.4 [24.4-28.5]
NS	3.5^{Footnote ↓}^{Footnote *} [1.9-5.1]	54.6 [51.2-58.0]	6.4 [4.4-8.4]	^{Footnote #}	9.9 [7.2-12.6]	^{Footnote #}	^{Footnote #}	^{Footnote #}	21.9 [18.6-25.2]
QC	^{Footnote #}	74.4 [71.2-77.6]	4.8 [3.9-5.7]	^{Footnote #}	6.0^{Footnote *} [3.7-8.2]	^{Footnote #}	^{Footnote #}	^{Footnote #}	11.2 [8.0-14.3]
ON	^{Footnote #}	59.8 [52.0-67.5]	4.5^{Footnote ↓}^{Footnote *} [2.1-6.8]	^{Footnote #}	12.9^{Footnote *} [6.8-19.0]	^{Footnote #}	^{Footnote #}	^{Footnote #}	18.0 [14.7-21.2]
MB	^{Footnote #}	55.7 [41.5-69.9]	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
SK	^{Footnote #}	60.4 [55.9-65.0]	5.9 [4.7-7.1]	^{Footnote #}	13.1 [9.0-17.2]	^{Footnote #}	^{Footnote #}	^{Footnote #}	16.2 [13.7-18.8]
AB	^{Footnote #}	61.2 [58.4-64.1]	5.7^{Footnote *} [3.6-7.8]	^{Footnote #}	10.5^{Footnote ↑} [8.4-12.6]	^{Footnote #}	^{Footnote #}	^{Footnote #}	16.6 [14.3-18.9]
BC	^{Footnote #}	61.1 [57.8-64.5]	3.6^{Footnote *} [1.7-5.6]	^{Footnote #}	12.1 [9.1-15.2]	^{Footnote #}	^{Footnote #}	^{Footnote #}	19.5^{Footnote ↑} [15.6-23.4]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote b High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to footnote # referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Estimates may not sum to 100 percent due to rounding. Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 14. Sources of cigarettes among students who smoked one or more cigarettes in the past
30 days^{Footnote 1}, by province, Canada^{Footnote 2}, 2021-22
	Social sources				Retail sources		Other (%)
	Buy them from a friend or someone else (%)	Ask someone to buy them for me (%)	Sibling, parent, friend, or someone else gives them to me (%)	Take them from my parent or sibling (%)	Buy them myself at a store (%)	Buy them from a First Nation Reserve (i.e., delivery service) or on a First Nation Reserve (%)	Other (%)
Canada^{Footnote 2}	13.8 [10.8-16.8]	7.0^{Footnote *} [4.3-9.8]	39.9 [34.0-45.8]	6.4 [4.6-8.3]	20.4^{Footnote *} [12.0-28.8]	3.9^{Footnote *} [2.4-5.4]	8.5^{Footnote ↑}^{Footnote *} [5.4-11.7]
NL	26.3 [22.1-30.5]	^{Footnote #}	33.4 [27.7-39.0]	^{Footnote #}	12.0 [8.1-15.8]	^{Footnote #}	12.3 [9.1-15.5]
PE	29.0 [23.4-34.6]	^{Footnote #}	36.6 [32.4-40.8]	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
NS	20.3 [15.4-25.2]	^{Footnote #}	33.6 [27.0-40.3]	9.1 [6.2-12.0]	^{Footnote #}	^{Footnote #}	13.6 [10.4-16.8]
QC	16.1 [11.8-20.3]	^{Footnote #}	35.0 [29.4-40.5]	^{Footnote #}	14.4^{Footnote *} [9.2-19.7]	^{Footnote #}	^{Footnote #}
ON	^{Footnote #}	^{Footnote #}	46.1 [35.0-57.3]	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
MB	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
SK	16.6 [13.3-19.9]	16.3 [11.3-21.3]	38.2 [33.5-43.0]	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
AB	13.7 [10.0-17.4]	^{Footnote #}	33.3 [26.6-40.0]	^{Footnote #}	15.6^{Footnote *} [9.7-21.5]	^{Footnote #}	11.4^{Footnote *} [6.1-16.7]
BC	13.9 [10.3-17.4]	^{Footnote #}	39.8 [31.8-47.8]	^{Footnote #}	15.5^{Footnote ↓}^{Footnote *} [8.3-22.6]	^{Footnote #}	^{Footnote #}
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote b High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to footnote # referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Estimates may not sum to 100 percent due to rounding. Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 15. Sources of vaping devices among students who vaped with nicotine in the past 30 days^{Footnote 1}, by province, Canada^{Footnote 2}, 2021-22
	Social sources			Retail sources			Other (%)
	Ask someone to buy them for me (%)	Family member, friend, or someone else gives them to me (bought, borrowed, shared) (%)	Use a parent's, sibling's, or someone else's without their permission (%)	Buy them from a vape shop (in person) (%)	Buy them from a convenience store (%)	Buy them online (%)	Other (%)
Canada^{Footnote 2}	20.3 [17.6-23.0]	51.5^{Footnote ↑} [48.5-54.6]	1.7 [1.2-2.2]	10.4 [8.2-12.5]	7.0^{Footnote *} [3.7-10.3]	2.1^{Footnote *} [1.3-2.9]	7.0 [5.5-8.5]
NL	24.5^{Footnote ↓} [21.5-27.5]	48.9 [46.0-51.7]	^{Footnote #}	12.2 [10.1-14.2]	^{Footnote #}	2.7^{Footnote *} [1.5-3.9]	9.1 [7.5-10.8]
PE	17.2 [14.9-19.4]	59.1 [55.8-62.4]	^{Footnote #}	9.4 [6.7-12.0]	^{Footnote #}	4.8^{Footnote *} [2.7-6.9]	6.0 [4.4-7.5]
NS	14.1 [11.7-16.6]	52.6 [49.5-55.8]	^{Footnote #}	14.2 [9.6-18.9]	^{Footnote #}	7.6^{Footnote *} [3.5-11.7]	7.3 [5.7-8.9]
QC	26.8 [22.5-31.2]	46.3 [40.2-52.3]	2.2^{Footnote *} [1.3-3.1]	8.7^{Footnote *} [5.7-11.7]	7.7^{Footnote *} [2.8-12.7]	^{Footnote #}	7.0 [5.6-8.5]
ON	18.0^{Footnote *} [11.6-24.3]	56.6 [50.2-63.1]	^{Footnote #}	6.5^{Footnote ↑}^{Footnote *} [3.4-9.6]	^{Footnote #}	^{Footnote #}	6.7^{Footnote *} [3.1-10.2]
MB	15.3^{Footnote *} [8.0-22.7]	44.9 [30.4-59.5]	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
SK	22.7 [18.9-26.5]	47.1 [40.8-53.5]	^{Footnote #}	15.5^{Footnote ↓} [11.4-19.5]	5.2^{Footnote *} [2.6-7.9]	^{Footnote #}	6.7 [5.1-8.4]
AB	20.1 [15.7-24.6]	44.8 [40.8-48.8]	^{Footnote #}	18.0 [14.3-21.7]	6.3^{Footnote *} [2.9-9.7]	^{Footnote #}	7.2 [5.5-8.8]
BC	18.1 [13.5-22.8]	54.3 [48.6-59.9]	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	7.8 [5.6-9.9]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote b High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to footnote # referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Estimates may not sum to 100 percent due to rounding. Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 16. Sources of vaping e-liquids or pods among students who vaped with nicotine in the past 30 days^{Footnote 1}, by province, Canada^{Footnote 2}, 2021-22
	Social sources			Retail sources			Other (%)
	Ask someone to buy them for me (%)	Family member, friend, or someone else gives them to me (bought, borrowed, shared) (%)	Use a parent's, sibling's, or someone else's without their permission (%)	Buy them from a vape shop (in person) (%)	Buy them from a convenience store (%)	Buy them online (%)	Other (%)
Canada^{Footnote 2}	21.0 [18.1-23.9]	50.4 [47.3-53.5]	1.5^{Footnote ↑} [1.1-2.0]	10.1 [7.8-12.4]	7.5^{Footnote ↑}^{Footnote *} [4.2-10.8]	1.7^{Footnote *} [1.0-2.5]	7.7 [6.3-9.1]
NL	22.3 [19.5-25.1]	52.3 [49.1-55.4]	^{Footnote #}	10.2 [8.4-12.0]	^{Footnote #}	^{Footnote #}	10.2 [8.7-11.7]
PE	17.5^{Footnote ↓} [14.2-20.7]	59.7 [55.3-64.1]	^{Footnote #}	8.2^{Footnote *} [5.4-11.1]	^{Footnote #}	4.9 [3.4-6.3]	6.8 [5.3-8.3]
NS	14.1 [11.8-16.4]	53.9 [49.0-58.8]	^{Footnote #}	13.9 [9.7-18.2]	^{Footnote #}	6.5^{Footnote ↓}^{Footnote *} [2.9-10.0]	8.1 [5.7-10.6]
QC	26.7 [22.1-31.4]	45.8 [39.2-52.4]	1.8^{Footnote *} [1.0-2.7]	8.6^{Footnote *} [5.1-12.1]	8.5^{Footnote ↓}^{Footnote *} [3.1-13.9]	^{Footnote #}	7.2 [5.6-8.9]
ON	19.2^{Footnote *} [12.5-25.8]	54.8 [48.9-60.7]	^{Footnote #}	6.8^{Footnote *} [3.2-10.4]	^{Footnote #}	^{Footnote #}	7.6^{Footnote *} [4.2-11.0]
MB	^{Footnote #}	35.0^{Footnote *} [18.5-51.6]	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
SK	24.2 [20.3-28.1]	45.6 [41.3-50.0]	^{Footnote #}	14.2 [10.4-18.1]	5.4^{Footnote *} [2.5-8.2]	^{Footnote #}	8.0 [6.0-10.0]
AB	21.9 [17.5-26.3]	44.2 [41.5-47.0]	^{Footnote #}	16.6 [12.5-20.7]	6.5^{Footnote ↓}^{Footnote *} [3.0-9.9]	^{Footnote #}	7.0 [5.5-8.4]
BC	15.9 [11.7-20.2]	54.6 [46.9-62.2]	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	9.2 [7.2-11.2]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote b High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to footnote # referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Estimates may not sum to 100 percent due to rounding. Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 17. Past-30-day use of cigarettes, e-cigarettes, any tobacco product by self-reported mental health and gender^{Footnote 1}, Canada^{Footnote 2}, 2021-22
	Total		Men/boys		Women/girls		Transgender, gender diverse, and/or questioning
	Excellent, very good, or good mental health (%)	Fair or poor mental health (%)	Excellent, very good, or good mental health (%)	Fair or poor mental health (%)	Excellent, very good, or good mental health (%)	Fair or poor mental health (%)	Excellent, very good, or good mental health (%)	Fair or poor mental health (%)
Cigarettes^{Footnote 3}	2.2 [1.6-2.8]	7.1 [5.5-8.7]	2.5^{Footnote ↑} [1.7-3.3]	7.8^{Footnote *} [4.8-10.8]	1.5^{Footnote ↑}^{Footnote *} [0.9-2.1]	6.2 [4.9-7.5]	^{Footnote #}	9.7^{Footnote *} [6.4-13.0]
E-cigarettes^{Footnote 4}	11.8 [9.8-13.8]	25.0 [22.4-27.6]	11.9 [9.6-14.2]	22.8 [18.5-27.1]	11.2 [9.0-13.5]	26.9 [24.2-29.7]	14.0^{Footnote *} [8.1-19.9]	19.4 [16.8-22.0]
E-cigarettes with nicotine	11.1 [9.1-13.2]	23.3 [20.8-25.8]	11.1 [8.7-13.6]	21.6 [17.3-26.0]	10.8 [8.7-13.0]	25.2 [22.6-27.7]	13.0^{Footnote *} [7.1-19.0]	16.3 [13.3-19.3]
E-cigarettes without nicotine	3.1 [2.5-3.7]	6.3 [5.3-7.3]	3.5^{Footnote ↑} [2.7-4.4]	5.6 [4.0-7.1]	2.0^{Footnote *} [1.3-2.7]	6.2 [5.5-6.9]	^{Footnote #}	7.1^{Footnote *} [4.2-10.0]
Any tobacco product^{Footnote 5}	3.8 [3.0-4.5]	9.8 [8.0-11.6]	4.4 [3.3-5.4]	10.7 [7.7-13.7]	2.3 [1.7-3.0]	8.8 [7.2-10.4]	8.6^{Footnote *} [4.0-13.1]	11.7 [8.2-15.1]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Smoked one or more cigarettes in the past 30 days. Return to footnote 3 referrer Footnote 4 Use of e-cigarettes with nicotine, without nicotine, and/or with an unknown content. Return to footnote 4 referrer Footnote 5 "Any tobacco product" includes past-30-day use of cigarettes, cigars, little cigars or cigarillos, heated tobacco products, smokeless tobacco, and waterpipe tobacco. E-cigarettes are excluded. Return to footnote 5 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote b High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to footnote # referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 18. Past-30-day use of cigarettes, e-cigarettes, any tobacco product by past-30-day experience with bullying and gender^{Footnote 1}, Canada^{Footnote 2}, 2021-22
	Total				Men/boys				Women/girls				Transgender, gender diverse, and/or questioning
	Experienced bullying^{Footnote 3}		Bullied others^{Footnote 4}		Experienced bullying		Bullied others		Experienced bullying		Bullied others		Experienced bullying		Bullied others
	Yes (%)	No (%)	Yes (%)	No (%)	Yes (%)	No (%)	Yes (%)	No (%)	Yes (%)	No (%)	Yes (%)	No (%)	Yes (%)	No (%)	Yes (%)	No (%)
Cigarettes^{Footnote 5}	5.5^{Footnote ↓} [4.4-6.5]	3.5^{Footnote ↑} [2.6-4.5]	9.9 [8.0-11.8]	3.4 [2.4-4.3]	4.3 [3.2-5.5]	3.5^{Footnote ↑} [2.4-4.6]	8.7 [6.4-11.0]	3.2^{Footnote *} [2.1-4.4]	4.5^{Footnote ↑} [3.1-5.9]	3.4 [2.5-4.4]	6.8 [4.8-8.8]	3.4 [2.6-4.2]	9.6^{Footnote *} [6.0-13.2]	6.6^{Footnote *} [3.6-9.7]	17.9^{Footnote *} [11.4-24.3]	6.6^{Footnote *} [3.1-10.1]
E-cigarettes^{Footnote 6}	22.2 [20.1-24.3]	15.1 [12.7-17.4]	32.4 [28.4-36.4]	14.7 [12.6-16.8]	16.6 [12.5-20.7]	13.7 [11.1-16.2]	27.3 [21.7-32.8]	12.8 [10.4-15.2]	25.9 [23.6-28.1]	16.6 [13.6-19.6]	36.9 [33.0-40.8]	16.6 [14.1-19.2]	19.3 [15.1-23.5]	14.8 [11.6-18.0]	28.9 [21.1-36.7]	15.5^{Footnote ↓} [13.0-18.0]
E-cigarettes with nicotine	20.6 [18.5-22.7]	14.2 [11.9-16.6]	31.1 [27.2-35.1]	13.7 [11.6-15.8]	15.0 [10.8-19.2]	13.0 [10.4-15.7]	26.0 [20.5-31.4]	12.0 [9.5-14.5]	24.4 [22.2-26.6]	15.6 [12.8-18.5]	35.7 [31.8-39.6]	15.6 [13.2-17.9]	17.2 [13.1-21.3]	13.2 [9.7-16.7]	27.4 [19.8-35.1]	12.7 [9.3-16.0]
E-cigarettes without nicotine	6.6 [5.6-7.6]	3.4 [2.9-4.0]	10.3 [7.8-12.8]	3.5^{Footnote ↓} [2.9-4.1]	6.0 [4.2-7.9]	3.3 [2.6-4.0]	9.4 [6.8-12.0]	3.2 [2.5-4.0]	6.1 [4.9-7.3]	3.4 [2.6-4.1]	8.6 [6.4-10.7]	3.5^{Footnote ↑} [2.9-4.1]	5.2 [3.7-6.7]	4.8^{Footnote *} [2.6-6.9]	6.8^{Footnote *} [4.1-9.4]	5.6^{Footnote *} [3.3-7.9]
Any tobacco product^{Footnote 7}	8.3 [6.9-9.7]	5.3 [4.2-6.4]	15.2 [12.3-18.0]	4.9 [3.9-6.0]	6.5^{Footnote ↑} [5.0-8.1]	5.7 [4.2-7.2]	13.1 [10.0-16.2]	5.2 [3.7-6.6]	7.4 [6.3-8.6]	4.6 [3.6-5.7]	12.0 [8.7-15.2]	4.6 [3.6-5.5]	12.4^{Footnote *} [8.1-16.8]	8.6^{Footnote *} [5.5-11.8]	24.2^{Footnote *} [16.0-32.4]	8.2^{Footnote *} [4.8-11.6]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Includes students who responded "Daily or almost daily", "2 or 3 times a week", "About once a week", or "Less than once a week" to the question, "In the last 30 days, how often have you been bullied by other students?" Return to footnote 3 referrer Footnote 4 Includes students who responded "Daily or almost daily", "2 or 3 times a week", "About once a week", or "Less than once a week" to the question, "In the last 30 days, how often did you bully other students?" Return to footnote 4 referrer Footnote 5 Smoked one or more cigarettes in the past 30 days. Return to footnote 5 referrer Footnote 6 Use of e-cigarettes with nicotine, without nicotine, and/or with an unknown content. Return to footnote 6 referrer Footnote 7 "Any tobacco product" includes past-30-day use of cigarettes, cigars, little cigars or cigarillos, heated tobacco products, smokeless tobacco, and waterpipe tobacco. E-cigarettes are excluded. Return to footnote 7 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 19. Past twelve-month use^{Footnote 1} and mean age at first use of alcohol and cannabis^{Footnote 2}, by grouped grades, Canada^{Footnote 3}, 2021-2022
	Total		Grades 7-9^{Footnote 4}		Grades 10-12^{Footnote 5}
	(%)	Mean age	(%)	Mean age	(%)	Mean age
Alcohol	39.0 [34.6-43.4]	13.1 [13.0-13.2]	22.7 [19.9-25.5]	11.7 [11.6-11.8]	55.7 [49.0-62.4]	13.7 [13.6-13.8]
High Risk Drinking^{Footnote 6}	20.8 [17.9-23.7]	14.3 [14.2-14.4]	8.4 [7.0-9.9]	12.8 [12.6-12.9]	33.6 [28.7-38.6]	14.7 [14.6-14.8]
Energy Drinks/Alcohol	17.7 [15.9-19.5]	N/A	12.0 [10.5-13.4]	N/A	23.5^{Footnote ↓} [20.9-26.1]	N/A
High Alcohol/Sweetened Drinks^{Footnote 7}	18.0 [15.7-20.2]	N/A	9.5^{Footnote ↑} [8.2-10.9]	N/A	26.5^{Footnote ↑} [23.0-30.1]	N/A
Cannabis	18.3 [15.7-20.8]	14.1 [14.0-14.2]	7.9 [6.6-9.1]	12.6 [12.5-12.7]	29.1 [24.7-33.4]	14.6 [14.5-14.7]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 Cannabis includes marijuana, hash and hash oil. Return to footnote 2 referrer Footnote 3 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 3 referrer Footnote 4 Secondary I-III in Quebec. Return to footnote 4 referrer Footnote 5 Secondary IV-V in Quebec. Return to footnote 5 referrer Footnote 6 Five or more drinks on one occasion. Return to footnote 6 referrer Footnote 7 Sweetened high alcohol content beverages (7% alcohol or higher), (e.g., Four Loko, FCKD UP or Clubtails). Return to footnote 7 referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer N/A - cannot be established due to multiple entries included in category. Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 20. Past twelve-month use^{Footnote 1} and mean age at first use of alcohol and cannabis^{Footnote 2}, by gender, Canada^{Footnote 3}, 2021-2022
	Total		Man/Boy		Woman/Girl		Transgender, gender diverse, and/or questioning
	(%)	Mean age	(%)	Mean age	(%)	Mean age	(%)	Mean age
Alcohol	39.0 [34.6-43.4]	13.1 [13.0-13.2]	35.7 [30.8-40.7]	13.0 [12.9-13.1]	41.6 [37.0-46.2]	13.2 [13.1-13.3]	40.3 [34.7-45.9]	12.4 [12.1-12.7]
High Risk Drinking^{Footnote 4}	20.8 [17.9-23.7]	14.3 [14.2-14.4]	19.1 [15.6-22.6]	14.3 [14.2-14.5]	22.2 [19.4-25.1]	14.3 [14.2-14.5]	18.5^{Footnote ↑} [14.7-22.3]	13.7 [13.5-14.0]
Energy Drinks/Alcohol^{Footnote 5}	17.7 [15.9-19.5]	N/A	15.4 [13.1-17.6]	N/A	19.0 [17.2-20.8]	N/A	22.9 [19.2-26.6]	N/A
High Alcohol/Sweetened Drinks	18.0 [15.7-20.2]	N/A	14.7 [12.1-17.2]	N/A	20.9 [18.6-23.3]	N/A	17.1 [13.6-20.6]	N/A
Cannabis	18.3 [15.7-20.8]	14.1 [14.0-14.2]	16.2 [13.4-19.1]	14.2 [14.1-14.3]	19.5^{Footnote ↓} [16.6-22.3]	14.2 [14.1-14.3]	20.8 [15.5-26.0]	13.7 [13.4-14.0]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 Cannabis includes marijuana, hash and hash oil. Return to footnote 2 referrer Footnote 3 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 3 referrer Footnote 4 Five or more drinks on one occasion. Return to footnote 4 referrer Footnote 5 Sweetened high alcohol content beverages (7% alcohol or higher), (e.g., Four Loko, FCKD UP or Clubtails). Return to footnote 5 referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer N/A - cannot be established due to multiple entries included in category. Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 21. Past twelve-month use of cannabis^{Footnote 1}^{Footnote 2} by past twelve-month use of alcohol, by gender and grouped grades, Canada^{Footnote 3}, 2021-2022
	Used cannabis (%)	Did not use cannabis (%)
Grades 7-12
Used alcohol	16.7 [14.2-19.3]	21.9 [19.2-24.6]
Did not use alcohol	1.6 [1.4-1.9]	59.7 [55.3-64.1]
Man/boy
Used alcohol	14.9 [12.1-17.7]	20.6 [17.5-23.6]
Did not use alcohol	1.5^{Footnote ↑} [1.2-1.9]	63.0 [58.0-68.0]
Woman/girl
Used alcohol	18.1 [15.2-21.0]	23.2 [20.4-25.9]
Did not use alcohol	1.4 [1.1-1.7]	57.4 [52.9-61.8]
Transgender, gender diverse, and/or questioning
Used alcohol	17.3 [12.2-22.5]	22.5^{Footnote ↑} [18.5-26.5]
Did not use alcohol	3.7^{Footnote *} [2.0-5.3]	56.5^{Footnote ↓} [51.4-61.5]
Grades 7-9^{Footnote 4}
Used alcohol	6.4 [5.3-7.6]	15.9 [13.7-18.1]
Did not use alcohol	1.3 [1.0-1.6]	76.4 [73.6-79.1]
Grades 10-12^{Footnote 4}
Used alcohol	27.3 [23.0-31.6]	28.2 [24.4-31.9]
Did not use alcohol	2.0 [1.6-2.4]	42.5^{Footnote ↑} [35.9-49.2]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 Cannabis includes marijuana, hash and hash oil. Return to footnote 2 referrer Footnote 3 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 3 referrer Footnote 4 Secondary I-III in Quebec. Return to footnote 4 referrer Footnote 5 Secondary IV-V in Quebec. Return to footnote 5 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Estimates may not sum to 100 percent due to rounding. Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 22. Past twelve-month use of illegal and other drugs^{Footnote 1}, by grouped grades and gender, Canada^{Footnote 2}, 2021-2022
	Total (%)	Grades 7-9^{Footnote 3} (%)	Grades 10-12^{Footnote 4} (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)
Amphetamines	0.9 [0.7-1.1]	0.7 [0.5-0.8]	1.2 [0.8-1.6]	0.8 [0.6-1.0]	0.6 [0.4-0.8]	1.9^{Footnote *} [1.1-2.7]
MDMA (Ecstasy)	1.4 [1.1-1.6]	0.7 [0.6-0.9]	2.0 [1.6-2.5]	1.1 [0.9-1.4]	1.1 [0.8-1.5]	2.1^{Footnote *} [1.0-3.2]
Hallucinogens	4.0 [3.2-4.7]	1.9 [1.5-2.3]	6.1 [4.8-7.3]	3.6 [2.9-4.4]	3.7 [2.6-4.7]	6.1^{Footnote *} [2.8-9.5]
Heroin	0.8 [0.5-1.0]	0.6 [0.4-0.7]	1.0^{Footnote *} [0.6-1.4]	0.7 [0.5-0.9]	0.3^{Footnote *} [0.2-0.4]	1.5^{Footnote *}^{Footnote ↓} [0.7-2.2]
Cocaine	1.6 [1.2-1.9]	1.0 [0.7-1.2]	2.2 [1.6-2.8]	1.3 [1.0-1.6]	1.3^{Footnote *} [0.8-1.8]	2.3^{Footnote *} [1.4-3.2]
Salvia	0.7 [0.5-0.9]	0.5^{Footnote ↓} [0.3-0.6]	1.0^{Footnote *} [0.6-1.3]	0.6 [0.4-0.8]	0.3^{Footnote *} [0.2-0.5]	1.3^{Footnote *} [0.7-1.9]
Glue/Gas	1.3 [1.1-1.6]	1.3 [1.1-1.5]	1.4 [1.0-1.7]	1.1 [0.9-1.4]	0.8 [0.6-0.9]	4.7^{Footnote *} [2.9-6.6]
Synthetic Cannabinoids	3.4 [2.9-4.0]	2.1 [1.7-2.6]	4.7 [3.9-5.6]	2.6 [2.1-3.1]	3.7 [3.0-4.4]	4.8 [3.3-6.2]
BZP/TFMPP	0.6 [0.4-0.8]	0.4 [0.3-0.5]	0.9^{Footnote *} [0.5-1.2]	0.6 [0.4-0.7]	0.2^{Footnote *} [0.1-0.3]	1.3^{Footnote *} [0.6-1.9]
Bath Salts	0.8 [0.6-1.0]	0.7 [0.6-0.9]	1.0^{Footnote *} [0.6-1.3]	0.7 [0.5-0.9]	0.5^{Footnote ↓} [0.3-0.6]	1.7^{Footnote *} [1.1-2.3]
Other Psychoactive Substances^{Footnote 5}	0.9 [0.7-1.1]	0.6 [0.4-0.7]	1.2^{Footnote *} [0.7-1.6]	0.8 [0.5-1.0]	0.4^{Footnote *} [0.2-0.6]	1.8^{Footnote *} [0.9-2.7]
Any Illegal Drug^{Footnote 6}	6.6 [5.6-7.7]	3.8 [3.2-4.5]	9.5^{Footnote ↑} [7.8-11.2]	5.7 [4.6-6.7]	6.8 [5.5-8.1]	9.6^{Footnote *} [6.3-12.8]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Secondary I-III in Quebec. Return to footnote 3 referrer Footnote 4 Secondary IV-V in Quebec. Return to footnote 4 referrer Footnote 5 Other psychoactive substances include at least one of the following: 2Cs, NBOMe, tryptamines. Return to footnote 5 referrer Footnote 6 Includes at least one of any of the above drugs, excluding glue/gas. Return to footnote 6 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 23. Past twelve-month use of medications to get high^{Footnote 1}, by grouped grades and gender, Canada^{Footnote 2}, 2021-2022
	Total (%)	Grades 7-9^{Footnote 3} (%)	Grades 10-12^{Footnote 4} (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)
Sedatives/Tranquilizers	2.2 [2.0-2.5]	1.6 [1.4-1.8]	2.8 [2.3-3.3]	1.9 [1.6-2.1]	2.1 [1.5-2.6]	4.2^{Footnote *} [2.8-5.5]
Stimulants^{Footnote 5}	4.9 [4.5-5.4]	4.3 [3.7-4.8]	5.6 [4.8-6.4]	4.5^{Footnote ↑} [4.0-5.1]	4.5^{Footnote ↑} [4.0-5.1]	8.0 [6.1-9.9]
Treatment for ADHD	3.1 [2.7-3.4]	2.7 [2.3-3.1]	3.5^{Footnote ↓} [3.0-3.9]	3.4 [2.8-3.9]	2.5^{Footnote ↓} [2.0-3.0]	3.5^{Footnote ↑} [2.4-4.7]
Other Stimulants	2.7 [2.3-3.0]	2.2 [1.8-2.6]	3.2 [2.5-3.9]	1.8 [1.6-2.1]	2.8 [2.4-3.2]	6.1 [4.5-7.7]
Pain Relievers^{Footnote 6}	3.2 [2.8-3.7]	2.4 [2.1-2.7]	4.1 [3.4-4.8]	2.7 [2.1-3.2]	3.0 [2.6-3.5]	5.4 [4.2-6.6]
Oxycodone	1.4 [1.1-1.7]	0.8 [0.6-1.0]	2.0 [1.5-2.4]	1.0 [0.7-1.3]	1.1^{Footnote *} [0.7-1.6]	2.5^{Footnote *}^{Footnote ↑} [1.6-3.5]
Fentanyl	0.9 [0.7-1.2]	0.8 [0.6-0.9]	1.1^{Footnote *} [0.7-1.6]	0.8 [0.6-1.1]	0.5^{Footnote ↑} [0.4-0.7]	1.6^{Footnote *} [0.8-2.3]
Other Prescribed Pain Relievers	2.6 [2.2-3.0]	2.0 [1.7-2.3]	3.3 [2.6-4.0]	2.2 [1.6-2.7]	2.4 [2.1-2.7]	4.1 [2.9-5.2]
Pharmaceuticals^{Footnote 7}	7.4 [6.8-7.9]	6.1 [5.5-6.7]	8.6 [7.7-9.5]	6.6 [5.9-7.3]	7.1 [6.5-7.7]	11.4 [9.3-13.4]
Sleeping Medicine^{Footnote 8}	5.0 [4.5-5.5]	4.3 [3.8-4.8]	5.8 [5.0-6.6]	4.1 [3.6-4.6]	5.1 [4.5-5.7]	9.2 [7.3-11.2]
Dextromethorphan	5.7 [5.3-6.2]	5.2 [4.8-5.7]	6.2 [5.5-6.9]	5.4 [4.9-6.0]	5.4 [5.0-5.9]	7.2 [5.8-8.7]
Gravol^®	4.3 [3.8-4.8]	4.2 [3.7-4.7]	4.4 [3.8-5.1]	3.5^{Footnote ↑} [3.0-4.0]	4.5^{Footnote ↑} [4.0-5.0]	5.9 [4.5-7.4]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Secondary I-III in Quebec. Return to footnote 3 referrer Footnote 4 Secondary IV-V in Quebec. Return to footnote 4 referrer Footnote 5 Stimulants used to get high include at least one of following: medicine to treat ADHD (Ritalin^®, Concerta^®, Adderall^®, Dexedrine^®) and other stimulants (uppers and bennies). Return to footnote 5 referrer Footnote 6 Pain relievers used to get high include at least one of the following: oxycodone, fentanyl or other prescribed pain relievers (codeine, morphine, Tylenol 3^®etc.). Return to footnote 6 referrer Footnote 7 Psychoactive pharmaceutical drugs used to get high include at least one of the following: tranquilizers or sedatives (tranqs, downers); stimulants (uppers, bennies) or ADHD treatment; pain relievers (oxycodone, fentanyl or other prescribed pain relievers (codeine, morphine, Tylenol 3^®etc.)). Return to footnote 7 referrer Footnote 8 Includes Sleeping medicine from a store (Nytol^®, Unisom^®,.). Return to footnote 8 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 24. Past twelve-month use of alcohol, cannabis^{Footnote 1} and psychoactive pharmaceuticals^{Footnote 2}, by province^{Footnote 3}, Canada, 2021-2022
	Pop'n estimate ('000)	Alcohol (%)	High risk drinking^{Footnote 4} (%)	Cannabis (%)	Pharmaceuticals^{Footnote 5} (%)
Canada	2,160	39.0 [34.6-43.4]	20.8 [17.9-23.7]	18.3 [15.7-20.8]	7.4 [6.8-7.9]
NL	26	44.6 [42.6-46.7]	26.6 [24.6-28.6]	23.1 [21.5-24.8]	6.3 [5.5-7.0]
PE	10	39.9 [37.2-42.6]	24.9 [22.6-27.3]	17.8 [16.0-19.6]	5.7 [5.0-6.5]
NS	55	41.6 [38.5-44.7]	24.9 [21.8-28.0]	24.0 [21.2-26.9]	7.1 [6.1-8.2]
QC^{Footnote 6}	396	47.0 [35.4-58.7]	23.2 [16.1-30.4]	14.8 [11.6-17.9]	9.6 [8.3-10.9]
ON	931	37.1 [29.2-45.0]	19.4 [14.3-24.4]	18.8 [13.7-24.0]	6.8 [5.8-7.7]
MB	86	40.7 [34.6-46.7]	21.6^{Footnote *} [14.3-28.9]	21.0^{Footnote *} [12.2-29.9]	7.2^{Footnote *} [3.5-10.8]
SK	71	43.8 [40.9-46.8]	28.0 [25.1-31.0]	21.4 [17.7-25.1]	7.4 [6.4-8.4]
AB	287	31.5^{Footnote ↑} [23.4-39.7]	17.0 [12.0-22.1]	15.6 [12.6-18.7]	7.2 [6.2-8.2]
BC	298	39.1 [29.8-48.4]	22.3^{Footnote *} [14.7-29.8]	20.5^{Footnote *}^{Footnote ↑} [13.4-27.6]	6.7 [5.4-8.1]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 Cannabis includes marijuana, hash and hash oil. Return to footnote 2 referrer Footnote 3 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 3 referrer Footnote 4 Five or more drinks on one occasion. Return to footnote 4 referrer Footnote 5 Psychoactive pharmaceutical drugs used to get high include at least one of the following: tranquilizers or sedatives (tranqs, downers); stimulants (uppers, bennies) or ADHD treatment; pain relievers (oxycodone, fentanyl or other prescribed pain relievers (codeine, morphine, Tylenol 3^®etc.)). Return to footnote 5 referrer Footnote 6 Secondary I-V in Québec. Return to footnote 6 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 25. Past twelve-month use of alcohol, cannabis^{Footnote 1} and psychoactive pharmaceuticals^{Footnote 2}, by grade, Canada^{Footnote 3}, 2021-2022
	Pop'n estimate ('000)	Alcohol (%)	High risk drinking^{Footnote 4} (%)	Cannabis (%)	Pharmaceuticals^{Footnote 5} (%)
Grade 7^{Footnote 6}	354	11.2 [9.3-13.2]	3.2 [2.4-3.9]	2.6 [1.9-3.2]	4.6 [4.0-5.3]
Grade 8^{Footnote 7}	356	21.8 [18.9-24.8]	6.8 [5.5-8.2]	6.1 [5.1-7.1]	5.9 [5.2-6.6]
Grade 9^{Footnote 8}	384	33.9 [28.6-39.3]	14.8 [11.9-17.8]	14.4 [11.6-17.2]	7.7 [6.4-9.1]
Grade 10^{Footnote 9}	383	49.0 [43.3-54.6]	26.4 [22.5-30.3]	23.0 [19.9-26.0]	8.9 [7.8-9.9]
Grade 11^{Footnote 10}	382	56.7 [49.5-63.9]	34.7 [28.8-40.5]	29.0 [22.9-35.1]	8.5^{Footnote ↑} [7.1-9.9]
Grade 12^{Footnote 11}	301	62.8 [53.6-72.0]	41.6 [34.8-48.4]	37.0 [31.4-42.5]	8.4 [6.8-10.1]
Total (grades 7-12)	2,160	39.0 [34.6-43.4]	20.8 [17.9-23.7]	18.3 [15.7-20.8]	7.4 [6.8-7.9]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 Cannabis includes marijuana, hash and hash oil. Return to footnote 2 referrer Footnote 3 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 3 referrer Footnote 4 Five or more drinks on one occasion. Return to footnote 4 referrer Footnote 5 Psychoactive pharmaceutical drugs used to get high include at least one of the following: tranquilizers or sedatives (tranqs, downers); stimulants (uppers, bennies) or ADHD treatment; pain relievers (oxycodone, fentanyl or other prescribed pain relievers (codeine, morphine, Tylenol 3^®etc.)). Return to footnote 5 referrer Footnote 6 Secondary I in Québec. Return to footnote 6 referrer Footnote 7 Secondary II in Québec. Return to footnote 7 referrer Footnote 8 Secondary III in Québec. Return to footnote 8 referrer Footnote 9 Secondary IV in Québec. Return to footnote 9 referrer Footnote 10 Secondary V in Québec. Return to footnote 10 referrer Footnote 11 Excludes Québec. Return to footnote 11 referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 26. Past twelve-month methods of cannabis consumption^{Footnote 1}^{Footnote 2} among users, by grouped grades and gender, Canada^{Footnote 3}, 2021-2022
	Total (%)	Grades 7-9^{Footnote 4} (%)	Grades 10-12^{Footnote 5} (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)
Smoked (a joint, bong, pipe, or blunt)	72.3 [70.0-74.7]	69.0 [66.2-71.8]	73.4 [70.9-75.9]	72.6 [69.4-75.7]	72.3 [69.1-75.6]	72.5^{Footnote ↓} [63.2-81.7]
Eaten in food (brownies, cakes, cookies, or candy)	48.9 [46.3-51.5]	45.6 [41.4-49.9]	49.9 [47.2-52.6]	47.3 [42.6-52.1]	49.4 [45.9-52.8]	55.7 [49.0-62.4]
Drank it (tea, cola, alcohol or other drinks)	15.8 [13.7-17.9]	19.8 [15.2-24.5]	14.6 [12.6-16.5]	17.4 [13.8-21.1]	13.1 [11.0-15.1]	16.7 [12.9-20.5]
Vaporized (vaped) dried cannabis^{Footnote 6}	34.1 [31.0-37.1]	39.9 [35.7-44.1]	32.3 [29.1-35.4]	35.5^{Footnote ↑} [31.6-39.4]	32.2 [28.0-36.3]	29.3 [20.9-37.8]
Vaporized (vaped) liquid cannabis^{Footnote 7}	54.0 [50.7-57.3]	54.3 [48.7-59.9]	54.0 [49.6-58.4]	54.8 [50.5-59.1]	53.0 [49.5-56.6]	47.3 [41.2-53.3]
Dabbed^{Footnote 8}	18.8 [16.9-20.8]	20.4 [16.8-24.0]	18.3 [16.1-20.5]	21.5^{Footnote ↑} [18.7-24.3]	16.0 [13.7-18.2]	16.5^{Footnote ↓} [12.4-20.5]
Used it some other way	23.1 [21.1-25.2]	28.9 [25.2-32.6]	21.4 [19.3-23.4]	24.4 [21.0-27.8]	20.9 [18.8-23.0]	26.5^{Footnote ↑} [20.4-32.7]
[95% confidence intervals in brackets] Footnote 1 Multiple methods of consumption were reported by users. Return to footnote 1 referrer Footnote 2 Student responses with missing values are not included in this analysis. Return to footnote 2 referrer Footnote 3 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 3 referrer Footnote 4 Secondary I-III in Québec. Return to footnote 4 referrer Footnote 5 Secondary IV-V in Québec. Return to footnote 5 referrer Footnote 6 A method of administration of cannabis whereby a dried cannabis flower product or by-product is heated below the temperature of combustion, thus turned into vapour (not smoke), and inhaled by a person. Return to footnote 6 referrer Footnote 7 A method of administration of cannabis whereby a liquid cannabis product or by-product is heated below the temperature of combustion, thus turned into vapour (not smoke), and inhaled by a person. This includes vaping concentrates/extracts using a vape pen. Return to footnote 7 referrer Footnote 8 A method of administration of a cannabis concentrate by inhaling the vapours produced as a result of contact of the concentrate with a very hot surface. Return to footnote 8 referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 27. Past twelve-month use of alcohol and other drugs and medications on the same occasion^{Footnote 1}, by grouped grades and gender, Canada^{Footnote 2}, 2021-2022
	Total (%)	Grades 7-9^{Footnote 3} (%)	Grades 10-12^{Footnote 4} (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)
Amphetamines	0.7 [0.5-0.9]	0.6 [0.4-0.7]	0.8^{Footnote *} [0.5-1.1]	0.6^{Footnote *} [0.4-0.9]	0.3^{Footnote *} [0.2-0.4]	1.1^{Footnote *} [0.6-1.6]
MDMA (Ecstasy)	0.9 [0.7-1.2]	0.6 [0.5-0.8]	1.3 [0.9-1.6]	0.8^{Footnote *} [0.5-1.1]	0.6^{Footnote *} [0.3-0.9]	1.8^{Footnote *} [0.7-2.9]
Hallucinogens	1.9 [1.5-2.3]	1.3 [1.0-1.7]	2.5^{Footnote ↑} [1.9-3.1]	1.7 [1.3-2.2]	1.5^{Footnote *}^{Footnote ↑} [1.0-2.1]	2.9^{Footnote *} [1.7-4.2]
Heroin	0.6 [0.5-0.8]	0.6 [0.4-0.7]	0.7^{Footnote *} [0.4-1.0]	0.6^{Footnote *} [0.4-0.8]	0.2^{Footnote *} [0.1-0.3]	1.1^{Footnote *} [0.6-1.7]
Cocaine	1.1 [0.8-1.4]	0.8 [0.6-1.0]	1.4 [1.0-1.9]	0.8^{Footnote *} [0.6-1.1]	0.9^{Footnote *} [0.4-1.4]	1.3^{Footnote *} [0.8-1.8]
ADHD Medications	1.4 [1.2-1.7]	1.2 [1.0-1.4]	1.7 [1.3-2.1]	1.3 [1.0-1.7]	1.1 [0.9-1.4]	2.1 [1.5-2.7]
Sedatives/Tranquilizers	1.1 [0.8-1.3]	0.8 [0.6-0.9]	1.4 [1.0-1.8]	1.0 [0.7-1.2]	0.7 [0.5-0.9]	2.0^{Footnote *} [1.2-2.8]
Prescription Pain Relievers^{Footnote 5}	1.5^{Footnote ↓} [1.0-1.9]	1.3^{Footnote *} [0.8-1.8]	1.6 [1.2-2.1]	1.2 [0.8-1.6]	1.3^{Footnote *} [0.7-2.0]	1.9^{Footnote *} [1.1-2.8]
Sleeping medicine^{Footnote 6}	1.6 [1.3-1.9]	1.6 [1.2-2.1]	1.5^{Footnote ↑} [1.1-2.0]	1.3 [0.9-1.6]	1.4 [1.0-1.7]	3.0^{Footnote *} [2.0-4.0]
Stimulants^{Footnote 7}	1.2 [1.0-1.5]	1.2 [0.9-1.5]	1.3 [0.9-1.7]	0.9 [0.7-1.2]	1.0 [0.8-1.3]	2.5^{Footnote *}^{Footnote ↓} [1.6-3.4]
Dextromethorphan	1.6 [1.3-1.8]	1.6 [1.3-2.0]	1.5^{Footnote ↓} [1.1-1.8]	1.5^{Footnote ↑} [1.1-1.9]	1.2 [1.0-1.4]	2.2^{Footnote *} [1.3-3.1]
Gravol^®	1.7 [1.5-1.9]	1.8 [1.5-2.2]	1.5^{Footnote ↑} [1.2-1.8]	1.4 [1.1-1.6]	1.6 [1.3-1.9]	2.6^{Footnote *} [1.7-3.4]
At least one of the above	5.0 [4.4-5.6]	4.5^{Footnote ↑} [3.9-5.1]	5.5^{Footnote ↓} [4.5-6.5]	4.1 [3.5-4.8]	5.1 [4.3-6.0]	7.1 [5.6-8.6]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Secondary I-III in Quebec. Return to footnote 3 referrer Footnote 4 Secondary IV-V in Quebec. Return to footnote 4 referrer Footnote 5 Pain relievers used to get high include at least one of the following: oxycodone, fentanyl or other prescribed pain relievers (codeine, morphine, Tylenol 3^®etc.). Return to footnote 5 referrer Footnote 6 Includes Sleeping medicine from a store (Nytol^®, Unisom^®,...). Return to footnote 6 referrer Footnote 7 Stimulants used to get high include diet pills, stay awake pills, uppers, bennies, wake-ups, etc. Return to footnote 7 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 28. Past twelve-month use of opioids with other drugs and medications on the same occasion^{Footnote 1}, by grouped grades and gender, Canada^{Footnote 2}, 2021-2022
	Total (%)	Grades 7-9^{Footnote 3} (%)	Grades 10-12^{Footnote 4} (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)
Amphetamines	0.6 [0.5-0.8]	0.5^{Footnote ↑} [0.4-0.7]	0.8^{Footnote *} [0.5-1.0]	0.6^{Footnote *} [0.4-0.9]	0.3^{Footnote *} [0.2-0.4]	1.2^{Footnote *} [0.7-1.8]
MDMA (Ecstasy)	0.7 [0.5-0.9]	0.5^{Footnote ↑} [0.4-0.7]	0.9 [0.6-1.1]	0.7^{Footnote *} [0.4-0.9]	0.4^{Footnote *} [0.2-0.6]	0.9^{Footnote *} [0.4-1.4]
Cocaine	0.9 [0.6-1.1]	0.7^{Footnote *} [0.4-1.0]	1.0^{Footnote *} [0.7-1.4]	0.7^{Footnote *} [0.4-0.9]	0.6^{Footnote *} [0.2-1.0]	1.0^{Footnote *} [0.6-1.5]
ADHD Medications	1.1 [0.8-1.3]	1.0 [0.8-1.3]	1.1 [0.8-1.4]	1.0 [0.7-1.2]	0.8^{Footnote *} [0.4-1.2]	1.8^{Footnote *} [1.1-2.5]
Stimulants^{Footnote 5}	1.0 [0.7-1.2]	0.9^{Footnote *} [0.6-1.2]	1.0 [0.7-1.4]	0.8 [0.5-1.0]	0.8^{Footnote *} [0.4-1.1]	1.8^{Footnote *} [1.0-2.5]
Sedatives/Tranquilizers	0.9 [0.6-1.1]	0.6 [0.5-0.8]	1.1^{Footnote *} [0.7-1.6]	0.6^{Footnote *} [0.4-0.9]	0.6^{Footnote *} [0.2-1.0]	1.5^{Footnote *}^{Footnote ↑} [0.8-2.2]
At least one of the above	1.8 [1.5-2.2]	1.7 [1.4-2.0]	1.9 [1.5-2.4]	1.5^{Footnote ↓} [1.2-1.8]	1.6^{Footnote *} [1.0-2.1]	3.1 [2.1-4.1]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Secondary I-III in Quebec. Return to footnote 3 referrer Footnote 4 Secondary IV-V in Quebec. Return to footnote 4 referrer Footnote 5 Stimulants used to get high include diet pills, stay awake pills, uppers, bennies, wake-ups, etc. Return to footnote 5 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 29. Past-30-day frequency of being bullied^{Footnote 1}, by grade group and gender, Canada^{Footnote 2}, 2021-2022
	Total (%)	Grades 7-9^{Footnote 3} (%)	Grades 10-12^{Footnote 4} (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)
Never in the last 30 days	79.0 [77.8-80.2]	74.8 [73.5-76.1]	83.3 [81.8-84.8]	82.6 [81.4-83.8]	76.8 [75.2-78.5]	59.0 [54.4-63.6]
Less than once a week	10.0 [9.3-10.6]	11.0 [10.3-11.7]	9.0 [8.0-9.9]	8.3 [7.6-9.0]	11.7 [10.8-12.6]	15.2 [13.5-16.9]
About once a week	4.3 [3.9-4.8]	5.3 [4.8-5.8]	3.3 [2.7-4.0]	3.4 [2.9-3.9]	5.0 [4.4-5.6]	8.7 [6.4-11.0]
2 or 3 times a week	3.3 [3.0-3.6]	4.5^{Footnote ↑} [4.1-4.9]	2.1 [1.7-2.5]	2.9 [2.5-3.2]	3.3 [2.9-3.8]	7.9 [6.1-9.8]
Daily or almost daily	3.4 [2.9-3.8]	4.4 [3.9-4.9]	2.3 [1.7-3.0]	2.9 [2.5-3.3]	3.1 [2.6-3.5]	9.3^{Footnote *} [6.2-12.3]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Secondary I-III in Québec. Return to footnote 3 referrer Footnote 4 Secondary IV-V in Québec. Return to footnote 4 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Estimates may not sum to 100 percent due to rounding. Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 30. Past-30-day ways of being bullied^{Footnote 1}, by grouped grades and gender, Canada^{Footnote 2}, 2021-2022
	Total (%)	Grades 7-9^{Footnote 3} (%)	Grades 10-12^{Footnote 4} (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)
Physical attacks	5.3 [4.7-5.8]	7.2 [6.5-7.9]	3.3 [2.6-4.0]	5.9 [5.2-6.7]	4.0 [3.5-4.5]	8.6 [6.3-10.9]
Verbal attacks	20.6 [19.5-21.7]	24.9 [23.6-26.1]	16.3 [14.9-17.6]	17.7 [16.6-18.7]	23.0 [21.4-24.6]	32.6 [28.5-36.7]
Non-verbal attacks^{Footnote 5}	22.9 [21.7-24.0]	26.0 [24.6-27.4]	19.7 [18.4-21.0]	14.9 [13.7-16.1]	30.1 [28.3-31.9]	41.3 [36.9-45.8]
Cyber-attacks	10.3 [9.6-10.9]	12.1 [11.2-12.9]	8.5^{Footnote ↓} [7.8-9.2]	7.2 [6.4-8.0]	12.5^{Footnote ↑} [11.6-13.5]	19.4 [17.0-21.9]
Had someone steal from you or damage your things	9.0 [8.2-9.8]	11.8 [10.8-12.8]	6.2 [5.3-7.0]	9.0 [8.0-10.0]	8.5^{Footnote ↑} [7.6-9.5]	14.1 [11.4-16.8]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Secondary I-III in Québec. Return to footnote 3 referrer Footnote 4 Secondary IV-V in Québec. Return to footnote 4 referrer Footnote 5 E.g., being ignored, being left out or excluded, being given dirty looks, etc. Return to footnote 5 referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 31. Past-30-day frequency of bullying others^{Footnote 1}, by grade group and gender, Canada^{Footnote 2}, 2021-2022
	Total (%)	Grades 7-9^{Footnote 3} (%)	Grades 10-12^{Footnote 4} (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)
Never in the last 30 days	89.0 [88.2-89.7]	88.1 [87.2-89.0]	89.9 [88.8-90.9]	88.3 [87.3-89.2]	90.2 [89.2-91.2]	85.1 [82.2-88.1]
Less than once a week	6.5^{Footnote ↑} [5.9-7.1]	7.2 [6.5-7.9]	5.8 [5.0-6.6]	6.7 [5.9-7.5]	6.5^{Footnote ↑} [5.8-7.3]	8.1 [5.9-10.3]
About once a week	1.7 [1.5-1.8]	1.9 [1.7-2.2]	1.4 [1.2-1.6]	1.8 [1.6-2.1]	1.5^{Footnote ↓} [1.3-1.7]	2.3^{Footnote *} [1.4-3.1]
2 or 3 times a week	1.0 [0.9-1.2]	1.1 [0.9-1.3]	0.9 [0.7-1.2]	1.1 [0.9-1.3]	0.9 [0.7-1.1]	1.6^{Footnote *} [0.9-2.2]
Daily or almost daily	1.8 [1.4-2.1]	1.6 [1.3-1.8]	2.0 [1.4-2.6]	2.1 [1.5-2.7]	0.9 [0.7-1.1]	3.0^{Footnote *} [1.9-4.1]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Secondary I-III in Québec. Return to footnote 3 referrer Footnote 4 Secondary IV-V in Québec. Return to footnote 4 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Estimates may not sum to 100 percent due to rounding. Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 32. Past-30-day ways of bullying others^{Footnote 1}, by grouped grades and gender, Canada^{Footnote 2}, 2021-2022
	Total (%)	Grades 7-9^{Footnote 3} (%)	Grades 10-12^{Footnote 4} (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)
Physical attacks	3.5^{Footnote ↑} [3.1-3.9]	4.0 [3.6-4.5]	3.0 [2.5-3.5]	4.4 [3.9-4.9]	2.1 [1.8-2.5]	4.4 [3.0-5.7]
Verbal attacks	9.2 [8.5-9.9]	10.0 [9.2-10.9]	8.3 [7.4-9.3]	10.4 [9.4-11.5]	7.7 [7.0-8.4]	10.5^{Footnote ↓} [7.9-13.0]
Non-verbal attacks^{Footnote 5}	11.3 [10.5-12.0]	12.3 [11.4-13.2]	10.3 [9.4-11.1]	9.3 [8.4-10.2]	12.8 [11.8-13.8]	16.8 [13.9-19.7]
Cyber-attacks	4.0 [3.7-4.4]	4.2 [3.7-4.6]	3.9 [3.4-4.4]	4.1 [3.7-4.6]	3.3 [2.9-3.8]	5.3 [4.0-6.6]
Stolen from other students or damaged their things	2.2 [2.0-2.5]	2.4 [2.1-2.7]	2.1 [1.6-2.5]	2.6 [2.3-3.0]	1.2 [1.0-1.4]	3.6 [2.5-4.8]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Secondary I-III in Québec. Return to footnote 3 referrer Footnote 4 Secondary IV-V in Québec. Return to footnote 4 referrer Footnote 5 E.g., being ignored, being left out or excluded, being given dirty looks, etc. Return to footnote 5 referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 33. Self-reported physical health^{Footnote 1}, by grouped grades and gender, Canada^{Footnote 2}, 2021-2022
	Total (%)	Grades 7-9^{Footnote 3} (%)	Grades 10-12^{Footnote 4} (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)
Excellent	21.5^{Footnote ↑} [20.5-22.5]	23.1 [21.9-24.4]	19.9 [18.6-21.2]	25.4 [24.0-26.9]	18.8 [17.5-20.0]	8.8 [6.7-10.9]
Very good	34.6 [33.6-35.6]	34.1 [32.9-35.2]	35.1 [33.8-36.4]	34.9 [33.5-36.3]	35.7 [34.5-36.8]	21.3 [17.0-25.5]
Good	28.6 [27.5-29.7]	27.5^{Footnote ↑} [26.6-28.5]	29.7 [27.9-31.4]	27.1 [25.7-28.6]	29.7 [28.3-31.1]	34.3 [31.6-36.9]
Fair	11.0 [10.3-11.7]	10.6 [9.8-11.3]	11.5^{Footnote ↓} [10.5-12.5]	9.1 [8.4-9.9]	11.7 [10.6-12.7]	23.0 [19.9-26.0]
Poor	2.0 [1.8-2.2]	1.8 [1.4-2.1]	2.2 [2.0-2.5]	1.7 [1.4-1.9]	1.8 [1.4-2.2]	6.6 [4.9-8.3]
I don't know	2.3 [2.0-2.6]	3.0 [2.6-3.3]	1.6 [1.2-2.1]	1.7 [1.4-2.1]	2.4 [2.0-2.8]	6.1^{Footnote *} [3.9-8.4]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Secondary I-III in Québec. Return to footnote 3 referrer Footnote 4 Secondary IV-V in Québec. Return to footnote 4 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Estimates may not sum to 100 percent due to rounding. Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 34. Self-reported mental health^{Footnote 1}, by grouped grades and gender, Canada^{Footnote 2}, 2021-2022
	Total (%)	Grades 7-9^{Footnote 3} (%)	Grades 10-12^{Footnote 4} (%)	Man/boy (%)	Woman/girl (%)	Transgender, gender diverse, and/or questioning (%)
Excellent	14.6 [13.6-15.6]	17.2 [16.1-18.3]	11.9 [10.6-13.2]	21.4 [20.0-22.8]	8.5^{Footnote ↑} [7.6-9.4]	4.2^{Footnote *} [2.4-6.0]
Very good	22.0 [21.1-23.0]	24.2 [23.0-25.4]	19.7 [18.5-20.9]	27.9 [26.4-29.4]	17.3 [16.3-18.2]	6.8 [5.1-8.5]
Good	24.5^{Footnote ↑} [23.7-25.3]	23.1 [22.2-24.1]	25.9 [24.4-27.4]	25.1 [24.2-26.1]	25.7 [24.5-26.9]	10.5^{Footnote ↑} [8.9-12.2]
Fair	20.5^{Footnote ↑} [19.9-21.2]	18.7 [17.8-19.6]	22.4 [21.4-23.4]	15.3 [14.4-16.2]	25.6 [24.6-26.7]	26.9 [24.4-29.3]
Poor	14.4 [13.2-15.6]	12.6 [11.5-13.6]	16.3 [14.2-18.3]	7.5^{Footnote ↓} [6.6-8.3]	18.3 [16.9-19.7]	44.7 [41.6-47.7]
I don't know	4.0 [3.5-4.4]	4.1 [3.6-4.6]	3.8 [2.9-4.7]	2.8 [2.4-3.2]	4.6 [3.8-5.4]	6.9 [4.7-9.1]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Secondary I-III in Québec. Return to footnote 3 referrer Footnote 4 Secondary IV-V in Québec. Return to footnote 4 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Estimates may not sum to 100 percent due to rounding. Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 35. Perceived risk of harm from using alcohol, cannabis, and prescription medication^{Footnote 1}^{Footnote 2} Canada^{Footnote 3}, 2021-2022
	Once in a while				On a regular basis
	Drinking alcohol (%)	Smoking cannabis (%)	Other than smoking it, using cannabis (%)	Use prescribed medication "to get high" (%)	Drinking alcohol (%)	Smoking cannabis (%)	Other than smoking it, using cannabis (%)	Use prescribed medication "to get high" (%)
No risk	36.8 [34.4-39.2]	17.6 [16.1-19.2]	16.6 [15.0-18.2]	8.1 [7.2-8.9]	7.0 [6.1-7.9]	8.6 [7.6-9.5]	9.1 [8.2-10.1]	6.4 [5.6-7.3]
Slight risk	38.5^{Footnote ↓} [37.1-39.8]	28.9 [27.2-30.7]	25.3 [23.5-27.1]	12.8 [12.1-13.4]	14.8 [13.5-16.2]	10.0 [8.9-11.2]	10.9 [9.3-12.4]	3.6 [3.2-4.1]
Moderate risk	11.9 [10.8-13.1]	28.4 [27.0-29.8]	27.0 [25.7-28.3]	32.7 [31.0-34.4]	34.9 [32.9-36.9]	24.1 [22.3-25.9]	23.5^{Footnote ↓} [22.0-25.0]	12.0 [11.4-12.5]
Great risk	6.6 [5.5-7.6]	16.1 [14.5-17.6]	17.7 [16.0-19.4]	32.8 [31.7-33.9]	36.8 [34.4-39.3]	48.0 [45.4-50.6]	43.4 [41.0-45.9]	64.0 [62.6-65.4]
I do not know	6.2 [5.5-6.9]	9.0 [8.2-9.7]	13.3 [12.5-14.1]	13.6 [12.6-14.6]	6.5^{Footnote ↓} [5.8-7.2]	9.3 [8.6-10.0]	13.1 [12.3-13.8]	13.9 [13.0-14.8]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 Prescription medications include prescribed pain relievers, tranquilizers, and/or medicine to treat ADHD. Return to footnote 2 referrer Footnote 3 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 3 referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Estimates may not sum to 100 percent due to rounding. Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 36. Past twelve-month substance use by self-reported mental health and gender^{Footnote 1}, Canada^{Footnote 2}, 2021-2022
	Total (%)		Men/boys (%)		Women/girls (%)		Transgender, gender diverse, and/or questioning (%)
	Excellent, very good, or good mental health (%)	Fair or poor mental health (%)	Excellent, very good, or good mental health (%)	Fair or poor mental health (%)	Excellent, very good, or good mental health (%)	Fair or poor mental health (%)	Excellent, very good, or good mental health (%)	Fair or poor mental health (%)
Alcohol	33.5^{Footnote ↑} [28.6-38.5]	49.3 [45.6-53.0]	33.2 [28.1-38.4]	44.5^{Footnote ↓} [39.4-49.5]	32.9 [27.6-38.1]	52.8 [48.8-56.8]	38.2 [27.1-49.3]	42.3 [37.6-47.0]
High-Risk Drinking^{Footnote 3}	17.0 [14.1-20.0]	27.6 [24.6-30.6]	17.2 [13.8-20.5]	25.6 [21.1-30.2]	16.2 [13.3-19.0]	29.7 [26.4-33.0]	17.3^{Footnote *} [9.0-25.7]	20.0 [16.4-23.5]
Energy drinks and alcohol	13.3 [11.3-15.2]	25.0 [23.3-26.7]	12.9 [10.7-15.2]	22.7 [19.9-25.4]	12.9 [10.8-14.9]	26.0 [24.1-27.8]	19.7^{Footnote *} [13.0-26.3]	24.2 [20.1-28.3]
Sweetened/high alcohol drinks^{Footnote 4}	13.6 [11.3-15.9]	25.2 [23.2-27.3]	12.6 [10.1-15.1]	21.1 [18.3-24.0]	14.7 [12.3-17.2]	28.3 [26.0-30.6]	15.8^{Footnote *} [8.8-22.8]	17.9 [14.5-21.4]
Cannabis^{Footnote 5}	12.4 [10.3-14.5]	28.2 [25.2-31.2]	12.6 [10.3-14.9]	27.4 [22.9-31.8]	11.4 [9.1-13.8]	29.0 [25.7-32.3]	^{Footnote #}	24.1 [18.8-29.3]
Any illegal drug^{Footnote 6}	3.7 [2.9-4.4]	11.4 [9.6-13.2]	3.8 [3.0-4.6]	11.3 [9.2-13.4]	2.8 [2.1-3.5]	11.3 [9.3-13.3]	^{Footnote #}	11.0^{Footnote *} [7.2-14.9]
Pharmaceuticals^{Footnote 7}	4.8 [4.2-5.5]	11.2 [10.3-12.2]	5.4 [4.6-6.2]	10.2 [8.7-11.6]	3.5^{Footnote ↓} [2.8-4.1]	11.0 [10.0-12.1]	6.4^{Footnote *} [3.9-8.9]	12.5^{Footnote ↓} [10.0-15.0]
Over-the-counter medications^{Footnote 8}	6.9 [6.4-7.5]	13.6 [12.7-14.5]	7.3 [6.5-8.0]	12.4 [10.7-14.1]	5.8 [5.2-6.3]	13.6 [12.6-14.6]	9.2^{Footnote *} [5.4-13.0]	14.4 [11.9-17.0]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Five or more drinks on one occasion. Return to footnote 3 referrer Footnote 4 Sweetened high alcohol content beverages (7% alcohol or higher), (e.g., Four Loko, FCKD UP or Clubtails). Return to footnote 4 referrer Footnote 5 Cannabis includes marijuana, hash and hash oil. Return to footnote 5 referrer Footnote 6 Illegal drugs include at least one of the following: amphetamines, MDMA (Ecstasy), hallucinogens, heroin, cocaine, salvia, synthetic cannabinoids, BZP/TFMPP, bath salts, 2Cs, NBOMe, tryptamines. Return to footnote 6 referrer Footnote 7 Psychoactive pharmaceutical drugs used to get high include at least one of the following: tranquilizers or sedatives (tranqs, downers); stimulants (uppers, bennies) or ADHD treatment; pain relievers (oxycodone, fentanyl or other prescribed pain relievers (codeine, morphine, Tylenol 3^®etc.)). Return to footnote 7 referrer Footnote 8 Over-the-counter medications include at least one of the following: sleeping medicine (e.g., Nytol^®, Unisom^®, …), dextromethorphan, and Gravol^®. Return to footnote 8 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote b High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to footnote # referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 37. Past twelve-month substance use by past-30-day experience with bullying and gender^{Footnote 1}, Canada^{Footnote 2}, 2021-22
	Total				Men/boys				Women/girls				Transgender, gender diverse, and/or questioning
	Experienced bullying^{Footnote 3}		Bullied others^{Footnote 4}		Experienced bullying		Bullied others		Experienced bullying		Bullied others		Experienced bullying		Bullied others
	Yes (%)	No (%)	Yes (%)	No (%)	Yes (%)	No (%)	Yes (%)	No (%)	Yes (%)	No (%)	Yes (%)	No (%)	Yes (%)	No (%)	Yes (%)	No (%)
Alcohol	45.4 [42.1-48.7]	38.0 [33.3-42.7]	57.1 [53.2-61.0]	37.2 [32.7 -41.7]	39.0 [33.6-44.4]	35.5^{Footnote ↓} [30.4-40.6]	52.3 [47.1-57.5]	34.0 [29.0-39.0]	50.1 [46.9-53.3]	40.0 [35.0-45.0]	61.7 [57.8-65.7]	39.9 [35.2-44.6]	42.9 [37.6-48.3]	38.0 [29.1-46.9]	56.2 [47.6-64.7]	38.0 [31.6-44.4]
High-Risk Drinking^{Footnote 5}	24.1 [21.5 -26.7]	20.1 [17.2-23.1]	34.2 [30.7 -37.7]	19.3 [16.5-22.2]	20.1 [15.8-24.5]	19.0 [15.5-22.4]	30.5^{Footnote ↓} [25.1-35.9]	17.8 [14.5-21.1]	27.3 [24.6-29.9]	21.3 [18.2-24.4]	37.4 [33.7-41.2]	20.9 [17.9-23.9]	20.3 [15.0-25.6]	15.3 [10.9-19.8]	30.8 [21.8-39.8]	16.4 [11.8-21.0]
Energy drinks and alcohol	23.5^{Footnote ↑} [21.7-25.3]	15.9 [14.2-17.7]	32.8 [29.3-36.3]	15.8 [14.2-17.4]	17.9 [14.8-20.9]	14.3 [12.1-16.4]	28.3 [24.0-32.6]	13.5^{Footnote ↑} [11.5-15.5]	26.2 [24.6-27.8]	17.1 [15.1-19.1]	34.6 [31.0-38.2]	17.4 [15.7-19.1]	26.6 [21.2-32.0]	18.7 [14.0-23.4]	36.4 [29.2-43.5]	20.3 [15.9-24.8]
Sweetened/high alcohol drinks^{Footnote 6}	22.9 [20.5-25.3]	16.8 [14.6 -18.9]	31.4 [28.0-34.7]	16.4 [14.2-18.6]	17.6 [13.3-22.0]	13.8 [11.7-16.0]	25.7 [21.2-30.2]	13.2 [10.8-15.5]	26.7 [24.6-28.8]	19.7 [17.0-22.4]	35.9 [32.3-39.4]	19.5^{Footnote ↑} [17.1-22.0]	20.0 [15.1-24.9]	13.6 [10.0-17.2]	29.7 [21.6-37.7]	14.7 [10.6-18.9]
Cannabis^{Footnote 7}	21.6 [18.8-24.3]	17.5^{Footnote ↑} [14.9-20.1]	32.9 [28.7-37.0]	16.6 [14.1-19.0]	17.0 [13.2-20.8]	16.1 [13.3-18.9]	29.0 [23.4-34.6]	14.7 [12.1-17.3]	23.9 [20.8-26.9]	18.4 [15.2-21.5]	34.8 [30.6-38.9]	18.0 [15.1-20.8]	22.8 [17.3-28.3]	19.6 [14.2-25.0]	36.7 [28.0-45.4]	18.2^{Footnote *} [12.1-24.3]
Any illegal drug^{Footnote 8}	9.8 [8.5-11.0]	5.7 [4.7-6.8]	17.2 [14.9-19.4]	5.3 [4.3-6.2]	7.2 [5.9-8.5]	5.3 [4.1-6.5]	13.5^{Footnote ↓} [11.3-15.7]	4.6 [3.6-5.6]	10.1 [8.5-11.7]	5.8 [4.4-7.1]	16.6 [13.5-19.7]	5.7 [4.6-6.9]	11.9 [8.4-15.5]	7.5^{Footnote *}^{Footnote ↑} [3.8-11.3]	23.5^{Footnote ↓} [15.9-31.0]	7.2^{Footnote *} [3.6-10.7]
Pharmaceuticals^{Footnote 9}	11.5^{Footnote ↓} [10.1-12.9]	6.1 [5.5-6.6]	17.9 [15.7-20.1]	5.9 [5.5-6.3]	9.8 [7.2-12.4]	5.5^{Footnote ↑} [4.9-6.1]	15.2 [11.9-18.6]	5.3 [4.7-5.8]	10.5^{Footnote ↑} [9.4-11.7]	6.0 [5.3-6.7]	14.7 [13.1-16.3]	6.2 [5.6-6.8]	16.0 [12.2-19.8]	8.2 [6.1-10.2]	26.9 [19.5-34.3]	8.5^{Footnote ↓} [6.5-10.4]
Over-the-counter medications^{Footnote 10}	14.5^{Footnote ↑} [13.1-16.0]	7.9 [7.4-8.5]	21.2 [19.1-23.3]	7.9 [7.4-8.4]	11.5^{Footnote ↑} [9.1-14.0]	7.5^{Footnote ↓} [6.7-8.3]	17.8 [14.7-20.9]	7.2 [6.6-7.8]	14.6 [13.1-16.2]	7.9 [7.2-8.6]	20.5^{Footnote ↑} [18.0-23.1]	8.1 [7.5-8.7]	17.5^{Footnote ↓} [13.9-21.0]	10.3 [7.7-13.0]	27.7 [20.8-34.7]	10.7 [8.4-13.0]
[95% confidence intervals in brackets] Footnote 1 Student responses with missing values are not included in this analysis. Return to footnote 1 referrer Footnote 2 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 2 referrer Footnote 3 Includes students who responded "Daily or almost daily", "2 or 3 times a week", "About once a week", or "Less than once a week" to the question, "In the last 30 days, how often have you been bullied by other students?" Return to footnote 3 referrer Footnote 4 Includes students who responded "Daily or almost daily", "2 or 3 times a week", "About once a week", or "Less than once a week" to the question, "In the last 30 days, how often did you bully other students?" Return to footnote 4 referrer Footnote 5 Five or more drinks on one occasion. Return to footnote 5 referrer Footnote 6 Sweetened high alcohol content beverages (7% alcohol or higher), (e.g., Four Loko, FCKD UP or Clubtails). Return to footnote 6 referrer Footnote 7 Cannabis includes marijuana, hash and hash oil. Return to footnote 7 referrer Footnote 8 Illegal drugs include at least one of the following: amphetamines, MDMA (Ecstasy), hallucinogens, heroin, cocaine, salvia, synthetic cannabinoids, BZP/TFMPP, bath salts, 2Cs, NBOMe, tryptamines. Return to footnote 8 referrer Footnote 9 Psychoactive pharmaceutical drugs used to get high include at least one of the following: tranquilizers or sedatives (tranqs, downers); stimulants (uppers, bennies) or ADHD treatment; pain relievers (oxycodone, fentanyl or other prescribed pain relievers (codeine, morphine, Tylenol 3^®etc.)). Return to footnote 9 referrer Footnote 10 Over-the-counter medications include at least one of the following: sleeping medicine (e.g. Nytol^®, Unisom^®,...), dextromethorphan, and Gravol^®. Return to footnote 10 referrer Footnote a Moderate sampling variability, interpret with caution. Return to footnote * referrer Footnote c Rounds up to a whole number. Return to footnote ↑ referrer Footnote d Rounds down to a whole number. Return to footnote ↓ referrer Source: Canadian Student Tobacco, Alcohol and Drugs Survey 2021-22.

Table 38. Sample size, by province and grade, Canada^{Footnote 1}, 2021-2022
	Grade 7^{Footnote 2}	Grade 8^{Footnote 3}	Grade 9^{Footnote 4}	Grade 10^{Footnote 5}	Grade 11^{Footnote 6}	Grade 12^{Footnote 7}	Total
Canada	12,436	12,500	11,055	10,218	8,859	6,028	61,096
NL	1,297	1,300	1,419	1,112	1,034	870	7,032
PE	814	854	785	818	703	642	4,616
NS	1,673	1,708	1,376	836	754	652	6,999
QC	2,596	2,399	2,196	1,954	1,718	0	10,863
ON	1,235	1,326	1,164	1,136	1,004	880	6,745
MB	879	839	647	258	252	225	3,100
SK	1,168	1,139	998	960	706	625	5,596
AB	1,359	1,257	1,167	2,209	1,833	1,435	9,260
BC	1,415	1,678	1,303	935	855	699	6,885
Footnote 1 New Brunswick declined to participate in the 2021-22 cycle of the Canadian Student Tobacco, Alcohol and Drugs Survey. Return to footnote 1 referrer Footnote 2 Secondary I in Québec. Return to footnote 2 referrer Footnote 3 Secondary II in Québec. Return to footnote 3 referrer Footnote 4 Secondary III in Québec. Return to footnote 4 referrer Footnote 5 Secondary IV in Québec. Return to footnote 5 referrer Footnote 6 Secondary V in Québec. Return to footnote 6 referrer Footnote 7 Excludes Québec. Return to footnote 7 referrer Source: Canadian Student Tobacco, Alcohol, and Drugs Survey 2021-2022.

Page details

Date modified:: 2024-03-19

Language selection

Search

Detailed tables for the Canadian Student Tobacco, Alcohol and Drugs Survey 2021-2022

Page details